Medicinal chemistry - drug design, synthesis and evaluation [P1-0208]



h-index for scientific and professional works with overview of pure citations by years (2013-2023)


COBISS.SI-ID Title of the work Type Source Year Database CI 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
1. 2249073 Cytoplasmic steps of peptidoglycan biosynthesis 1.02 FEMS microbiol. rev. 2008 WoS 303 22 19 23 22 29 27 34 41 41 45 0
Scopus 332 23 20 29 23 30 30 34 48 48 45 2
2. 3299185 Antioxidant and antimicrobial activities of cinnamic acid derivatives 1.02 Mini rev. med. chem. 2012 WoS 283 4 11 17 19 23 30 38 47 51 43
Scopus 299 4 11 17 20 25 31 39 54 50 45 3
3. 22940455 Electrically tunable liquid crystal optical microresonators 1.01 Nat. photonics 2009 WoS 222 24 27 15 25 27 17 30 22 24 10 1
Scopus 230 22 28 17 24 29 18 32 22 25 11 2
4. 2548337 Rhodanine as a privileged scaffold in drug discovery 1.02 Curr. med. chem. 2009 WoS 178 11 23 25 13 15 18 15 22 22 14
Scopus 195 15 23 26 15 17 19 13 29 24 14
5. 3713393 Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor 1.01 J. med. chem. 2014 WoS 179 2 16 21 21 30 29 34 26
Scopus 184 2 16 22 21 32 31 32 26 2
6. 3690609 Bioactivation potential of thiophene-containing drugs 1.01 Chem. res. toxicol. 2014 WoS 162 11 11 19 31 22 32 19 15 2
Scopus 165 10 12 18 32 18 39 19 14 3
7. 2746993 Review of operating principle and applications of the charged aerosol detector 1.02 J. chromatogr., A 2010 WoS 128 19 11 9 17 13 9 15 13 13 9
Scopus 143 18 11 13 19 18 9 17 12 14 11 1
8. 3238001 Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation 1.02 Expert opinion on drug discovery 2012 WoS 121 12 11 9 15 16 15 13 4 12 14
Scopus 129 12 12 10 14 17 17 14 6 12 15
9. 2770545 C-type lectin DC-SIGN; an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity 1.02 Cell. signal. 2010 WoS 116 17 18 12 13 15 8 9 9 12 3
Scopus 127 19 18 13 17 15 8 9 10 13 5
10. 4785492 Effect of cell electroporation on the conductivity of a cell suspension 1.01 Biophys. j. 2005 WoS 107 7 12 10 15 10 10 9 14 10 10
Scopus 127 10 11 11 18 19 11 9 15 13 10
11. 4184177 Bisphenol A and its analogs 1.02 Environ Toxicol Pharmacol 2016 WoS 113 7 16 17 27 25 21
Scopus 118 6 18 19 25 25 21 4
12. 4882801 Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors 1.02 Drug resist. updat. 2020 WoS 110 13 40 54 3
Scopus 115 13 43 53 6
13. 2354289 EANM/ESC guidelines for radionuclide imaging of cardiac function 1.02 Eur. j. nucl. med. mol. imaging 2008 WoS 101 8 16 12 6 9 12 7 13 10 8
Scopus 112 11 22 14 7 7 15 8 14 5 9
14. 1761649 Recent advances in the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones and 3,4-dihydro-2H-1,4-benzoxazines 1.02 Tetrahedron 2005 WoS 88 14 11 9 8 8 5 5 10 13 3 2
Scopus 99 14 13 10 9 8 9 7 11 12 4 2
15. 19064067 Bicyclic boronate VNRX-5133 inhibits metallo- and serine-ß-lactamases 1.01 J. med. chem. 2019 WoS 93 1 34 32 26
Scopus 98 1 36 36 25
16. 2692209 EANM-EORTC general recommendations for sentinel node diagnostics in melanoma 1.02 Eur. j. nucl. med. mol. imaging 2009 WoS 78 8 13 13 9 8 6 10 5 3 3
Scopus 98 11 18 16 12 10 7 9 9 3 3
17. 4130929 Structural features of subtype-selective EP receptor modulators 1.02 Drug discov. today 2017 WoS 91 2 17 23 16 22 11
Scopus 97 2 17 26 16 24 11 1
18. 3616625 Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of mycobacterium tuberculosis inhA 1.01 J. med. chem. 2014 WoS 85 4 17 15 10 15 5 10 5 4
Scopus 96 5 18 16 10 16 7 11 7 5 1
19. 4033905 Hazard identification and risk characterization of bisphenols A, F and AF to aquatic organisms 1.01 Environ. pollut. 2016 WoS 83 2 8 13 12 15 15 18
Scopus 91 2 9 13 13 18 15 20 1
20. 3437937 Mutagenicity and DNA damage of bisphenol A and its structural analogs 1.01 Arh. hig. rada toksikol. 2013 WoS 76 3 1 6 8 14 13 8 13 10
Scopus 84 3 2 7 8 14 11 10 15 13 1
21. 1955697 Recent progress in diaryl ether synthesis 1.02 Synthesis 2006 WoS 83 19 4 8 10 7 7 6 10 8 4
Scopus 81 18 4 7 9 7 5 6 11 8 5 1
22. 4444017 The magic of crystal structure-based Inhibitor optimization 1.01 J. med. chem. 2018 WoS 78 1 17 17 17 24 2
Scopus 82 1 18 17 18 24 4
23. 30884135 The occurrence and source identification of bisphenol compounds in wastewaters 1.01 Sci. total environ. 2018 WoS 74 4 16 15 16 22 1
Scopus 81 5 18 12 19 23 4
24. 2839153 Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 1.01 Eur. j. nucl. med. mol. imaging 2010 WoS 63 1 9 7 1 7 4 9 14 6 4 1
Scopus 78 1 11 9 4 10 5 10 15 6 6 1
25. 3620721 Endocrine disruptome - an open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding 1.01 J. chem. inf. mod. 2014 WoS 69 4 8 9 4 13 7 13 11
Scopus 77 4 9 10 3 13 8 13 13 4
26. 4818033 Dual inhibitors of human DNA topoisomerase II and other cancer-related targets 1.02 J. med. chem. 2020 WoS 69 6 27 34 2
Scopus 77 7 30 38 2
27. 10300500 Cell electrofusion using nanosecond electric pulses 1.01 Sci. rep. 2013 WoS 63 3 3 6 11 9 11 3 8 8 1
Scopus 77 2 4 9 13 10 11 6 13 8 1
28. 4263537 Development of an in-vivo active reversible butyrylcholinesterase inhibitor 1.01 Sci. rep. 2016 WoS 72 4 6 13 18 14 17
Scopus 74 4 6 13 19 15 15 2
29. 4223601 Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation 1.01 Eur. j. med. chem. 2017 WoS 69 10 15 16 12 9 6 1
Scopus 74 10 16 17 13 10 6 2
30. 4309873 Xanthine oxidase inhibitors beyond allopurinol and febuxostat 1.02 Eur. j. med. chem. 2017 WoS 69 1 12 11 15 18 12
Scopus 73 1 13 9 15 21 13 1
31. 3969137 Glass fiber-supported TiO [sub] 2 photocatalyst 1.01 Appl. catal., B Environ. 2016 WoS 68 6 7 10 13 12 9 9 2
Scopus 72 6 8 10 12 13 10 10 3
32. 2876529 Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase 1.01 J. med. chem. 2010 WoS 64 5 13 7 4 6 4 8 9 4 4
Scopus 72 5 14 8 4 9 4 8 9 5 6
33. 26058457 Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children 1.01 Intensive Care Med 2009 WoS 62 14 7 6 9 7 1 7 6 4 1
Scopus 72 17 10 8 9 9 1 6 6 4 2
34. 5092943 Genotoxic activity of bisphenol A and its analogues bisphenol S, bisphenol F and bisphenol AF and their mixtures in human hepatocellular carcinoma (HepG2) cells 1.01 Sci. total environ. 2019 WoS 60 2 15 25 16 2
Scopus 68 2 15 26 19 6
35. 1699631 Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper- independent antileukaemic activity 1.01 Dalton trans. 2014 WoS 64 2 8 4 6 7 13 10 9 5
Scopus 66 2 8 4 7 6 13 11 8 6 1
36. 2514516 The influence of medium conductivity on electropermeabilization and survival of cells in vitro 1.01 Bioelectrochemistry 2001 WoS 60 3 6 6 3 5 5 9 11 7 4 1
Scopus 65 3 7 6 3 5 6 9 11 9 3 3
37. 4523889 Physiologically based pharmacokinetic PBPK modelling of bisphenol BPA, BPS, BPF, and BPAF with new experimental metabolic parametrics 1.01 Environ. health perspect. 2018 WoS 59 16 14 15 13 1
Scopus 64 14 12 17 16 5
38. 2622577 Influence of polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood 1.01 Leuk. lymphoma 2009 WoS 63 6 4 4 8 8 9 7 11 5 1
Scopus 63 8 4 4 8 8 9 7 10 4 1
39. 1536057027 Catalytic oxygenation of sp[sup]3 C-H bonds with Ir(III) complexes of chelating triazoles and mesoionic carbenes 1.01 Dalton trans. 2015 WoS 62 11 12 9 6 5 6 9 4
Scopus 63 11 10 10 6 6 6 9 5
40. 2904177 False positives in the early stages of drug discovery 1.02 Curr. med. chem. 2010 WoS 63 4 5 8 8 0 4 8 10 9 7
Scopus 61 4 5 8 8 0 4 8 12 7 5
41. 4706929 Efflux pump inhibitors of clinically relevant multidrug resistant bacteria 1.02 Med. res. rev. 2019 WoS 61 1 18 19 22 1
Scopus 62 20 20 21 1
42. 4144753 Novel multi-target-directed ligands for Alzheimer's disease 1.01 Eur. j. med. chem. 2016 WoS 55 13 6 13 12 5 6
Scopus 61 13 7 15 11 6 7 2
43. 4547697 Multi-target-directed ligands for treating Alzheimer's disease 1.01 Eur. j. med. chem. 2018 WoS 56 1 17 14 12 12
Scopus 60 1 17 14 13 12 3
44. 4145265 Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors 1.01 J. med. chem. 2016 WoS 58 2 7 12 15 12 10
Scopus 59 2 7 12 16 10 12 0
45. 3408497 Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes 1.01 Toxicol. in vitro 2013 WoS 52 1 3 4 6 4 7 3 5 11 8
Scopus 59 1 3 4 8 4 7 3 5 11 11 2
46. 24845827 Natural sources, pharmacokinetics, biological activities and health benefits of hydroxycinnamic acids and their metabolites 1.02 Nutrients 2020 WoS 51 1 14 33 3
Scopus 59 2 17 37 3
47. 1536240835 Ru [sup] II, Os [sup] II, and Ir [sup] III complexes with chelating pyridyl-mesoionic carbene ligands 1.01 Chemistry 2015 WoS 54 4 11 10 10 3 5 8 3
Scopus 56 4 10 10 10 4 5 9 4
48. 3889009 Discovery of 4,5,6,7-tetrahydrobenzo[1,2-d]thiazoles as novel DNA gyrase inhibitors targeting the ATP-binding site 1.01 J. med. chem. 2015 WoS 54 0 4 3 6 10 14 12 5 0
Scopus 56 1 3 4 8 10 14 11 5 0
49. 1959793 Inhibitors of Cathepsin B 1.01 Curr. med. chem. 2006 WoS 54 5 11 4 6 1 5 5 7 5 5
Scopus 55 5 12 6 6 2 4 5 7 5 3
50. 1708335 Exploring the scope of pyridyl- and picolyl-functionalized 1,2,3-triazol-5-ylidenes in bidentate coordination to ruthenium(II) cymene chloride complexes 1.01 Organometallics 2014 WoS 54 1 10 9 12 5 7 4 4 2
Scopus 55 1 10 9 12 5 7 4 5 2
51. 4085105 Influence of metabolism on endocrine activities of bisphenol S 1.01 Chemosphere 2016 WoS 53 0 2 15 9 9 8 10
Scopus 55 0 2 15 10 8 9 9 2
52. 1688433 Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method 1.01 Int. j. pharm. 2005 WoS 38 4 6 6 5 4 1 4 3 3 2
Scopus 55 10 7 8 5 7 1 5 5 4 3
53. 4768625 Development and optimization of liquid chromatography analytical methods by using AQbD principles 1.02 Org. process res. dev. 2019 WoS 53 2 22 28 1
Scopus 54 2 24 26 2
54. 38347267 Will morphing boron-based inhibitors beat the ß-lactamases? 1.02 Curr. opin. chem. biol. 2019 WoS 49 2 16 20 11
Scopus 54 2 19 21 12
55. 31019737 Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4-hydroxylase (CYP53) 1.01 J Appl Microbiol 2014 WoS 47 2 2 4 4 4 6 4 7 14
Scopus 52 2 2 4 4 5 5 5 10 15
56. 4614001 A road map for prioritizing warheads for cysteine targeting covalent inhibitors 1.01 Eur. j. med. chem. 2018 WoS 45 5 13 11 16
Scopus 52 6 14 13 16 3
57. 7524436 Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane complex formation 1.01 J. gene med. 2010 WoS 40 6 6 8 2 4 3 2 2 4 3
Scopus 52 7 8 8 3 11 4 2 2 4 3
58. 35127299 The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: Results from an online survey conducted in the early stages of the pandemic 1.01 Cancer 2020 WoS 51 4 24 23
Scopus 51 5 23 23
59. 3225201 Car-parrinello simulation of the vibrational spectrum of a medium strong hydrogen bond by two-dimensional quantization of the nuclear motion: application to 2-hydroxy-5-ntrobenzamide 1.01 J. phys. chem., B Mater. surf. interfaces biophys. 2012 WoS 50 5 6 3 9 7 8 5 4 1 2
Scopus 51 5 6 4 9 7 8 5 4 1 2
60. 6451540 The temperature effect during pulse application on cell membrane fluidity and permeabilization 1.08 Bioelectrochemistry 2008 WoS 49 1 5 3 7 6 3 2 4 9 9
Scopus 51 1 5 3 8 8 3 2 3 10 8
61. 1429084 Historic overview and recent advances in the synthesis of super-statins 1.02 Curr. org. chem. 2010 WoS 48 3 8 10 4 4 6 4 3 4 2
Scopus 51 3 8 11 5 4 7 3 3 3 4
62. 3794801 Design, synthesis and evaluation of new thiadiazole- based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis 1.01 J. med. chem. 2015 WoS 47 2 10 8 7 6 9 3 2
Scopus 51 2 11 9 7 5 10 4 3
63. 5901082 Stereoarrayed CF [sub] 3-substituted 1,3-diols by dynamic kinetic resolution 1.01 Angew. Chem. 2016 WoS 43 4 3 10 7 6 8 5
Scopus 51 4 3 9 8 6 12 8 1
64. 4602737 Design and development of Nrf2 modulators for cancer chemoprevention and therapy 1.02 Drug des. dev. ther. 2018 WoS 49 7 14 17 10 1
Scopus 48 8 13 16 10 1
65. 2357361 Recent advances in the synthesis of 1,2,4- and 1,3,4 oxadiazoles 1.02 Curr. org. chem. 2008 WoS 48 5 6 8 6 6 2 3 4 2 6
Scopus 49 5 6 8 7 6 2 3 4 3 5
66. 4889969 Systematic exploration of different E3 ubiquitin ligases 1.01 Chem. sci. 2020 WoS 47 4 18 23 2
Scopus 49 4 15 28 2
67. 2958449 Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship 1.02 Current drug metabolism 2011 WoS 46 5 1 1 5 13 7 9 3 2
Scopus 49 6 1 1 5 13 7 9 4 3
68. 1525340 Basic CuCO3/ligand as a new catalyst for 'on water' borylation of Michael acceptors, alkenes and alkynes: application to the efficient asymmetric synthesis of alpha-alcohol type sitagliptin side chain 1.01 Appl. organomet. chem. 2013 WoS 47 3 6 7 11 3 4 3 1 5 4
Scopus 47 3 6 7 10 3 4 3 1 6 4
69. 958833 Arginine mimetics 1.02 Tetrahedron 2001 WoS 44 5 9 10 3 5 5 2 1 3 1
Scopus 47 7 10 10 3 5 5 2 1 3 1
70. 4868465 Cannabinoid content in industrial hemp (Cannabis sativa L.) varieties grown in Slovenia 1.01 Ind. crops prod. 2020 WoS 42 6 17 18 1
Scopus 47 6 19 20 2
71. 1245809 Abuse of clenbuterol and its detection 1.01 Curr. med. chem. 2003 WoS 45 11 4 1 6 5 2 5 4 4 2 1
Scopus 46 10 4 2 5 6 3 5 4 4 2 1
72. 1537031875 Ru [sup] II, Ir [sup] III and Os [sup] II mesoionic carbene complexes 1.01 Dalton trans. 2016 WoS 43 2 8 8 4 9 9 3
Scopus 46 3 8 8 4 10 10 3
73. 2731377 In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B 1.01 Bioorg. med. chem. lett. 2010 WoS 40 7 4 6 3 1 5 1 7 4 2
Scopus 46 9 4 7 5 1 6 2 6 3 3
74. 6679380 Mechanisms involved in gene electrotransfer using high- and low-voltage pulses - an in vitro study 1.01 Bioelectrochemistry 2009 WoS 40 10 8 2 2 2 3 1 2 6 4
Scopus 46 10 8 2 2 4 3 0 5 8 4
75. 4363633 Antibacterial and beta-lactamase inhibitory activity of monocyclic beta-lactams 1.02 Med. res. rev. 2018 WoS 44 1 4 7 12 10 10
Scopus 45 2 3 6 12 10 11 1
76. 2752113 Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones 1.01 Eur. j. med. chem. 2010 WoS 43 3 7 4 2 5 3 6 5 4 4
Scopus 45 3 7 5 4 5 4 3 7 3 4
77. 3893361 LiSiCA 1.01 J. chem. inf. mod. 2015 WoS 41 3 3 2 10 7 5 11
Scopus 45 3 2 3 10 7 8 12
78. 3579761 Prospects for developing new antibacterials targeting bacterial type IIa topoisomerases 1.02 Curr. topics med. chem. 2013                          
Scopus 45 4 5 5 5 8 3 7 2 6 0
79. 4217457 Chemical profile, antioxidant activity and stability in stimulated gastrointestinal tract model system of three Verbascum species 1.01 Ind. crops prod. 2016 WoS 44 2 5 10 15 7 5
Scopus 44 2 4 9 15 7 7
80. 3806577 Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and ß-amyloid aggregation inhibitors with neuroprotective properties 1.01 Eur. j. med. chem. 2015 WoS 43 2 5 8 6 8 7 3 4
Scopus 44 1 5 10 6 7 9 2 4
81. 1536664003 A mesoionic bis(Py-tzNHC) palladium(II) complex catalyses "green" Sonogashira reaction through an unprecedented mechanism 1.01 Chem. commun. 2016 WoS 44 4 9 6 7 7 6 5
Scopus 43 4 9 8 5 7 5 5
82. 1694065 Azapeptides as pharmacological agents 1.01 Curr. med. chem. 2005 WoS 44 4 6 5 4 6 6 3 4 3 3
Scopus 43 4 6 5 4 6 7 2 4 3 2
83. 4747121 Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents 1.01 Eur. j. med. chem. 2019 WoS 41 5 12 13 11
Scopus 44 5 11 14 13 1
84. 2743921 5-benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases 1.01 ChemMedChem 2010 WoS 39 2 6 1 2 5 4 10 3 3 3
Scopus 44 2 6 1 1 6 6 7 5 4 6
85. 1623855 A selective approach to pyridine appended 1,2,3-triazolium salts 1.01 Org. lett. 2013 WoS 43 5 5 6 7 8 2 1 5 4
Scopus 43 5 5 6 7 8 2 1 5 4
86. 3024241 Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds 1.01 ChemMedChem 2011 WoS 42 0 4 4 6 2 5 4 9 4 4
Scopus 43 0 4 5 6 2 5 3 9 4 4 1
87. 3629169 Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F 1.02 Bioorg. chem. 2014 WoS 38 1 2 4 5 6 9 3 7 1
Scopus 42 1 2 4 5 6 11 3 9 1
88. 3134799 Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay 1.01 Chemosphere 2014 WoS 40 1 5 2 3 9 7 4 9
Scopus 41 1 5 2 3 9 7 5 9
89. 5312596 Cell membrane fluidity related to electroporation and resealing 1.01 Eur. biophys. j. 2006 WoS 38 1 3 5 2 3 7 3 6 7 1
Scopus 41 1 4 3 3 5 6 2 8 5 3 1
90. 3730312 Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome 1.01 J. dairy sci. 2016 WoS 36 1 2 5 6 7 12 3
Scopus 41 2 3 5 7 8 14 2
91. 3508081 The effect of lipid composition and liposome size on the release properties of liposomes-in-hydrogel 1.01 Int. j. pharm. 2013 WoS 39 2 7 5 7 2 2 6 3 5
Scopus 40 2 7 5 7 2 3 6 3 5
92. 1565020 CuII and Cu0 catalyzed mono borylation of unsaturated hydrocarbons with B2pin2: entering into the water 1.02 ChemCatChem 2014 WoS 40 4 6 5 7 4 3 9 2
Scopus 39 4 6 5 6 4 3 9 2
93. 4644465 Chemicals and drugs forming reactive quinone and quinone imine metabolites 1.02 Chem. res. toxicol. 2019 WoS 38 1 15 9 12 1
Scopus 40 16 12 11 1
94. 4571505 Antimicrobial activity of trans-cinnamic acid and commonly used antibiotics against important fish pathogens and non-pathogenic isolates 1.01 J Appl Microbiol 2018 WoS 38 9 5 12 10 2
Scopus 40 8 6 13 10 3
95. 27732441 Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 1.01 J. med. chem. 2011 WoS 36 3 7 1 3 2 4 2 5 4 5
Scopus 40 3 8 1 4 4 4 1 5 5 4 1
96. 9419604 Combination of microsecond and nanosecond pulsed electric field treatments for inactivation of Escherichia coli in water samples 1.08 J. membr. biol. 2012 WoS 31 1 5 4 3 3 5 1 5 3 1
Scopus 40 2 5 4 4 3 8 2 7 3 2
97. 2109041 Recent advances in the synthesis of unnatural [alpha]-amino acids 1.01 Curr. org. chem. 2007 WoS 39 3 4 5 6 4 3 4 4 3 3
Scopus 38 3 4 4 6 4 3 4 5 2 3
98. 1538148547 Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease 1.01 Chem. commun. 2019 WoS 38 6 7 9 16
Scopus 39 5 8 10 16 0
99. 3833713 Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with ß-amyloid anti-aggregation properties and beneficial effects on memory in vivo 1.01 Bioorg. med. chem. 2015 WoS 37 4 6 6 5 8 4 3 1
Scopus 39 1 4 6 6 7 8 4 2 1
100. 4444273 Inhibition of D-Ala 1.01 Nature communications 2017 WoS 37 8 9 11 9 0
Scopus 39 7 11 11 10 0
101. 4329841 Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease 1.02 Future medicinal chemistry 2017 WoS 39 1 4 11 9 8 5 1
Scopus 36 3 10 9 10 2 2
102. 3697521 Screening of bisphenol A, triclosan and paraben analogues as modulators of the glucocorticoid and androgen receptor activities 1.01 Toxicol. in vitro 2015 WoS 35 1 1 4 5 8 6 4 6
Scopus 39 2 2 5 5 8 6 5 6
103. 4248177 N-propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2- sulfonamide moieties 1.01 Bioorg. med. chem. 2017 WoS 35 4 3 10 9 6 2 1
Scopus 39 5 5 9 8 7 2 3
104. 3441009 Melanin is crucial for growth of the black yeast Hortaea werneckii in its natural hypersaline environment 1.01 Fungal biology 2013 WoS 35 1 2 1 3 3 2 5 7 11
Scopus 39 1 2 1 3 2 2 8 7 12 1
105. 3914865 Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol 1.01 Chem.-biol. interact. 2015 WoS 32 3 5 7 4 2 3 8
Scopus 39 4 5 7 4 2 6 10 1
106. 3370865 Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives 1.01 J. med. chem. 2013 WoS 38 2 3 4 7 1 6 5 2 4 4
Scopus 37 2 3 4 6 1 6 5 2 4 4
107. 2881905 Fluconazole cocrystals with dicarboxylic acids 1.01 Cryst. growth des. 2010 WoS 37 7 6 1 3 2 5 2 8 3
Scopus 38 7 6 1 4 2 6 2 8 2
108. 3019121 Structure-based design of a new series of D-Glutamic acid-based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD) 1.01 J. med. chem. 2011 WoS 36 2 2 4 5 5 4 8 2 1 3
Scopus 38 2 2 4 3 6 5 8 2 1 5
109. 1531740 A highly productive, whole-cell DERA chemoenzymatic process for production of key lactonized side-chain intermediates in statin synthesis 1.01 PloS one 2013 WoS 35 1 9 1 4 5 4 5 3 3
Scopus 38 2 10 2 4 6 3 5 4 2
110. 3849841 Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S 1.01 Toxicol. in vitro 2015 WoS 34 2 5 9 5 4 8 1
Scopus 38 3 6 11 5 4 7 1 1
111. 4168305 A new 'golden age' for the antitubercular target InhA 1.02 Drug discov. today 2017 WoS 33 1 5 6 8 7 6
Scopus 38 1 6 7 8 8 8
112. 4130673 Identification of novel chemical scaffolds inhibiting trypanothione synthetase from pathogenic trypanosomatids 1.01 PLoS negl. trop. dis. 2016 WoS 32 1 5 5 4 7 4 6
Scopus 38 5 9 3 8 4 8 1
113. 4284017 Determination of fagopyrins, rutin, and quercetin in Tartary buckwheat products 1.01 Lebensm.-Wiss. + Technol. 2017                          
Scopus 38 1 1 3 9 6 8 10
114. 14485287 A double-edged kinase lyn 1.01 J. exp. med. 1998 WoS 37 8 4 3 7 1 3 1 2 4 4
Scopus 37 9 5 4 5 1 3 1 1 4 4
115. 3874161 Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents 1.01 Bioorg. med. chem. 2015 WoS 35 5 7 4 7 3 3 5 1
Scopus 37 5 7 5 7 3 3 6 1
116. 4758897 Pharmacogenomics education in medical and pharmacy schools 1.01 Pharmacogenomics 2019 WoS 37 8 20 9
Scopus 35 2 3 23 7
117. 3107953 New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation 1.01 Eur. j. med. chem. 2011 WoS 35 3 7 2 3 4 1 5 4 3 3
Scopus 37 3 7 2 1 4 2 5 4 4 5
118. 75626755 E3 ligase ligands in successful PROTACs 1.02 Front. chem. 2021 WoS 33 3 29 1
Scopus 37 4 30 3
119. 3816561 Isoindoline-1,3-dione derivatives targeting cholinesterases 1.01 Bioorg. med. chem. 2015 WoS 32 1 5 2 4 9 5 4 2
Scopus 37 2 5 2 4 11 7 3 2 1
120. 2371697 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function 1.01 J. med. chem. 2008 WoS 31 2 3 7 3 8 1 1 5 1
Scopus 37 2 3 7 4 8 3 1 2 4 3
121. 4507249 Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. 1.02 Med. res. rev. 2019 WoS 36 3 7 13 13
Scopus 36 2 8 12 14
122. 4132209 Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair 1.01 Pharmacol. ther. 2016 WoS 36 3 7 6 7 10 3
Scopus 33 3 7 4 8 9 2
123. 3701274 Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase 1.01 J. mol. biol. 2007 WoS 33 3 3 3 0 4 1 6 3 7 3
Scopus 36 3 3 3 0 5 1 5 4 8 4
124. 3274865 Dual inhibitor of MurD and MurE ligases from Escherichia coli and Staphylococcus aureus 1.01 ACS Medicinal Chemistry Letters 2012 WoS 32 1 3 0 1 6 2 7 6 4 2
Scopus 36 1 3 1 0 7 3 5 7 5 4
125. 25801689 Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis 1.01 Drug metab. dispos. 2009 WoS 31 4 4 5 3 3 3 3 1 4 1
Scopus 36 3 6 6 3 3 3 3 1 5 3
126. 6812500 Electroporation in biological cell and tissue 1.16 Electrotechnologies for extraction from food plants and biomaterials 2008                          
Scopus 36 1 3 2 7 3 2 4 5 4 3 2
127. 4336241 Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA 1.01 Bioorg. med. chem. lett. 2017 WoS 32 7 9 7 5 4
Scopus 35 7 9 8 5 6
128. 4465009 Design, synthesis and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer's agents 1.01 ACS chem. neurosci. 2018 WoS 32 1 14 5 8 4
Scopus 34 1 15 4 9 4 1
129. 4033137 In vitro impact of bisphenols BPA, BPF, BPAF and 17ß estradiol (E2) on human monocyte-derived dendritic cell generation, maturation and function 1.01 International immunopharmacology 2016 WoS 31 2 5 4 4 5 5 5 1
Scopus 34 2 5 5 3 7 4 7 1
130. 3836017 Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones 1.01 Chem.-biol. interact. 2015 WoS 31 2 3 7 5 2 3 3 6
Scopus 34 2 3 7 5 2 4 3 8
131. 1518428 Application of flow photochemical bromination in the synthesis of a 5-bromomethylpyrimidine precursor of rosuvastatin: improvement of productivityand product purity 1.01 Org. process res. dev. 2013 WoS 30 1 6 3 6 1 4 2 2 3 2
Scopus 34 1 6 4 6 2 4 2 4 4 1
132. 4292465 Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors 1.01 Eur. j. med. chem. 2017 WoS 30 1 3 4 8 9 5
Scopus 33 1 4 5 8 10 5
133. 4470641 Novel multi-target-directed ligands aiming at symptoms and causes of Alzheimer's disease 1.01 ACS chem. neurosci. 2018 WoS 28 1 14 7 2 4
Scopus 33 1 17 6 2 6 1
134. 3346033 Lactic acid bacteria as oral delivery systems for biomolecules 1.01 Pharmazie 2012 WoS 26 1 1 1 6 4 6 1 4 1 1
Scopus 33 1 2 2 6 5 6 2 4 3 2
135. 1509980 Recent advances in the retro-claisen reaction and its synthetic applications 1.02 Current organic synthesis 2012 WoS 32 3 5 1 2 2 4 4 5 3 3
Scopus 32 3 5 1 2 2 4 4 4 3 4
136. 3452785 Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF 1.01 Eur. j. med. chem. 2013 WoS 31 5 2 5 5 5 3 6
Scopus 32 5 2 5 3 7 3 7
137. 3834225 Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity 1.01 Oncotarget 2015 WoS 32 4 2 4 6 8 4 4
Scopus 31 0 4 2 4 6 7 5 3
138. 4060698 Novel naphthalene-N-sulfonyl-d-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme 1.01 J. med. chem. 2008 WoS 30 4 3 3 2 1 7 4 4 2
Scopus 32 4 2 2 1 3 1 6 5 5 3
139. 4366193 Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores 1.01 EXCLI j. 2017 WoS 29 1 10 4 7 7
Scopus 32 1 10 5 8 7 1
140. 2744177 Advances in the chemistry of saccharins 1.02 Curr. med. chem. 2010 WoS 31 4 1 2 3 5 4 4 6 1 1
Scopus 31 4 1 2 3 5 4 4 5 2 1
141. 3160945 Reactivity of bisphenol A-3,4-quinone with DNA. A quantum chemical study 1.01 Toxicol. in vitro 2012 WoS 28 2 6 3 2 1 3 2 5 2 2
Scopus 31 2 6 3 2 1 4 2 5 2 4
142. 3194737 DC-SIGN antagonists, a potential new class of anti-infectives 1.02 Curr. med. chem. 2012 WoS 27 5 4 2 3 4 1 2 1 3 2
Scopus 31 8 4 4 3 3 1 2 1 3 2
143. 1536057283 Synthesis and NMR analysis of 1,4-disubstituted 1,2,3-triazoles tethered to pyridine, pyrimidine, and pyrazine rings 1.01 European journal of organic chemistry 2014 WoS 26 2 4 4 3 4 4 1 4
Scopus 31 3 4 4 3 5 4 3 5
144. 4387185 Accumulation of heavy metals from soil in medicinal plants 1.01 Arh. hig. rada toksikol. 2017 WoS 22 1 1 6 10 4
Scopus 31 1 2 8 12 7 1
145. 3538289 Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening 1.01 Eur. j. med. chem. 2013 WoS 30 1 6 5 3 1 4 3 3 3 1
Scopus 30 1 6 5 3 1 4 4 2 3 1
146. 11739732 Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro 1.01 Sci. rep. 2017 WoS 30 4 3 11 8 4
Scopus 30 4 5 9 8 4
147. 1896817 The application of freidinger lactams and their analogs in the design of conformationally constrained peptidomimetics 1.02 Curr. med. chem. 2006 WoS 30 5 5 3 2 2 5 2 4 2
Scopus 30 5 5 3 2 1 5 3 4 2
148. 4231793 Polymorphic variation in TPMT is the principal determinant of TPMT phenotype 1.01 Clinical pharmacology & therapeutics 2017 WoS 29 2 4 9 4 6 3 1
Scopus 30 2 5 9 4 7 3
149. 1479004 Iridium-catalyzed chemoselective and enantioselective hydrogenation of (1-chloro-1-alkenyl) boronic esters 1.01 Angew. Chem. 2012 WoS 29 4 6 2 2 2 2 1 2 4 4
Scopus 30 4 6 1 3 2 2 1 2 6 3
150. 4218737 TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions 1.01 eLife 2016 WoS 30 2 3 4 6 8 7
Scopus 27 2 3 3 6 7 6
151. 24820739 Escaping from Flatland 1.02 Chemistry 2021 WoS 27 13 14
Scopus 30 1 12 16 1
152. 2360433 Synthesis of novel DC-SIGN ligands with an [alpha]-fucosylamide anchor 1.01 ChemBioChem 2008 WoS 27 11 0 4 3 1 1 1 2 3 1
Scopus 30 12 0 5 3 1 1 2 1 4 1
153. 10952788 New insights into the mechanisms of gene electrotransfer - experimental and theoretical analysis 1.01 Sci. rep. 2015 WoS 27 0 3 5 2 4 5 4 4
Scopus 30 4 5 4 3 6 4 4
154. 3602801 Antimicrobial activity of the marine alkaloids, clathrodin and oroidin, and their synthetic analogues 1.01 Mar. drugs 2014 WoS 25 0 1 3 5 2 1 6 3 4
Scopus 30 0 1 5 6 2 2 6 4 4
155. 6387994 Stereoarrayed 2,3-disubstituted 1-indanols via ruthenium(II)-catalyzed dynamic kinetic resolution-asymmetric transfer hydrogenation 1.01 Org. lett. 2018 WoS 28 3 8 6 8 3
Scopus 29 2 9 4 10 4
156. 3557489 Chemical composition of the silver fir (Abies alba) bark extract Abigenol and its antioxidant activity 1.01 Ind. crops prod. 2014 WoS 28 0 0 1 3 7 3 3 10 1
Scopus 29 0 0 1 3 7 3 4 10 1
157. 2805617 Small molecule antagonists of integrin receptors 1.01 Curr. med. chem. 2010 WoS 26 7 4 3 6 1 1 1 1 1 1
Scopus 29 8 4 2 7 1 1 1 1 2 2
158. 2964849 ATP-binding site of bacterial enzymes as a target for antibacterial drug design 1.02 J. med. chem. 2011 WoS 26 4 8 1 2 3 1 4 2 1
Scopus 29 5 6 2 2 3 2 4 3 1 1 0
159. 2534001 Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach 1.01 Bioorg. med. chem. lett. 2009 WoS 24 3 2 0 1 4 1 5 5 1 2
Scopus 29 3 3 1 1 6 1 5 5 2 2
160. 4413297 Influence of different classes of crosslinkers on alginate polyelectrolyte nanoparticle formation, thermodynamics and characteristics 1.01 Carbohydr. polym. 2018 WoS 28 3 5 6 6 8
Scopus 28 3 5 6 6 8
161. 3835505 Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10 1.01 Xenobiotica 2015 WoS 26 1 3 4 5 4 5 4
Scopus 28 1 5 5 5 4 5 3
162. 2462321 Three-component one-pot synthetic route to 2-amino-5-alkylidenethiazol-4-ones 1.01 Tetrahedron 2009 WoS 26 4 7 2 3 2 2 2 3 1
Scopus 28 4 7 2 3 3 2 2 3 1 1
163. 8213332 Cell counting tool parameters optimization approach for electroporation efficiency determination of attached cells in phase contrast images 1.01 J. Microsc. 2011 WoS 23 7 7 1 2 2 1 3
Scopus 28 8 7 3 1 2 1 2 3 1
164. 2245489 Shape optimization and characterization of polysaccharide beads prepared by ionotropic gelation 1.01 J. microencapsul 2008 WoS 21 3 5 3 1 2 1 3 3
Scopus 28 5 5 3 3 2 4 3 3
165. 2485361 Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase 1.01 Bioorg. med. chem. lett. 2009 WoS 20 1 4 1 2 2 4 2 3 1
Scopus 28 1 4 1 3 4 1 4 3 3 3 1
166. 4050545 Nonpeptidic selective inhibitors of the chymotrypsin-like (ß5i) subunit of the immunoproteasome 1.01 Angew. Chem. 2016 WoS 27 2 6 6 1 3 6 3
Scopus 27 2 6 5 2 3 6 3
167. 1569630 Synthetic approaches to contemporary drugs that contain the cyclopropyl moiety 1.02 Synthesis 2020 WoS 27 3 10 13 1
Scopus 27 3 11 13
168. 31824089 Cell type-specific response to high intracellular loading of polyacrylic acid-coated magnetic nanoparticles 1.01 International journal of nanomedicine 2015 WoS 27 1 2 5 0 2 3 9 5
Scopus 27 2 2 5 0 3 2 8 4 1
169. 4736369 Synthesis of aminoboronic acid derivatives 1.02 Organic Chemistry Frontiers 2019 WoS 27 3 9 9 6
Scopus 26 1 10 9 6
170. 4240753 Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors 1.01 Bioorg. med. chem. 2017 WoS 26 2 6 4 7 3 4
Scopus 27 2 7 4 7 4 3 0
171. 3129713 Recent advances in the synthesis of unnatural [alpha]-amino acids - an updated version 1.02 Curr. org. chem. 2011 WoS 27 1 5 3 6 3 4 1 2 2
Scopus 26 2 5 3 5 3 3 1 3 1
172. 26093529 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease 1.01 Hum. immunol. 2009 WoS 25 6 2 4 1 5 2 2 2 1
Scopus 27 7 2 5 1 4 2 2 2 1 1
173. 7794297 Fagopyrin and flavonoid contents in common, Tartary, and cymosum buckwheat 1.03 J. food compos. anal. 2013 WoS 25 1 5 3 1 6 3 5 1
Scopus 27 2 5 2 2 6 3 5 2
174. 3363441 Environmental risk assessment of antimicrobials applied in veterinary medicine 1.02 Environ Toxicol Pharmacol 2013 WoS 18 3 1 0 4 3 1 4 2
Scopus 27 1 4 4 2 0 4 3 2 4 3
175. 2053233 Design, synthesis, biochemical evaluation and antimycobacterial action of phosphonate inhibitors of antigen 85C, a crucial enzyme involved in biosynthesis of the mycobacterial cell wall 1.01 Eur. j. med. chem. 2007 WoS 26 4 4 6 2 3 3 1 3
Scopus 25 4 4 6 2 3 3 1 2
176. 2767217 Monovalent and bivalent N-fucosyl amides as high affinity ligands for Pseudomonas aeruginosa PA-IIL lectin 1.08 Carbohydr. res. 2010 WoS 26 8 4 3 3 1 1 2 4
Scopus 25 8 4 3 3 1 1 3 2
177. 3030897 Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting d-Glu- and diphosphate-binding site 1.01 Eur. j. med. chem. 2011 WoS 24 3 3 2 2 3 4 4 1 2
Scopus 26 0 3 4 1 3 3 4 5 2 1
178. 2447217 Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients 1.01 Leukemia 2009 WoS 24 3 7 5 2 2 3 2
Scopus 26 3 8 4 3 2 3 3
179. 1724017 Synthesis of N-phthalimido [beta]-aminoethanesulfonyl chlorides:the use of chloride for a simple and efficient synthesis of new peptidosulfonamide building blocks 1.01 Tetrahedron lett. 2005 WoS 24 8 3 3 2 2 2 1 1 2
Scopus 26 8 5 4 2 2 2 1 1 1
180. 2988401 Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin-conjugates for targeting of the gastrin receptor 1.01 J. med. chem. 2011 WoS 24 2 1 4 1 1 2 2 8 2 1
Scopus 26 2 2 4 1 1 2 2 8 2 2
181. 2612441 Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice 1.01 J. exp. med. 1993 WoS 22 9 6 1 1 2 2 1
Scopus 26 11 1 6 1 1 3 1 2
182. 2027633 Arginine mimetic structures in biologically active antagonists and inhibitors 1.01 Curr. med. chem. 2006 WoS 16 3 4 2 2 2 1 1 1
Scopus 26 3 6 4 3 4 3 1 1 1
183. 24720601 Flavonoids, cinnamic acid derivatives as inhibitors of 17 ß-hydroxysteroid dehydrogenase type 1 1.08 Mol. cell. endocrinol. 2009 WoS 24 1 4 3 2 2 2 4 1 3 2
Scopus 25 1 4 3 2 2 1 3 3 2 2 2
184. 1813873 Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents 1.01 Bioorg. med. chem. lett. 2005 WoS 25 2 6 2 5 1 2 4 1 2
Scopus 24 2 6 2 4 1 2 4 1 2
185. 6147866 Stereopure functionalized benzosultams via ruthenium(II)-catalyzed dynamic kinetic resolution-asymmetric transfer hydrogenation 1.01 Org. lett. 2017 WoS 22 8 2 6 5 1
Scopus 25 8 2 5 8 2
186. 33728005 Comparison of isolation methods for the determination of buckwheat volatile compounds 1.01 Food chem. 2010 WoS 22 6 3 2 3 2 1 1 2 1 1
Scopus 25 6 4 1 2 3 2 2 1 2 1 1
187. 1900657 Cinnamic acids as new inhibitors of 17ß-hydroxysteroid dehydrogenase type 5 (AKR1C3) 1.08 Mol. cell. endocrinol. 2006 WoS 22 3 4 2 1 4 1 2 2 1 2
Scopus 25 3 5 2 1 4 3 2 2 1 2
188. 10675540 Cell electrofusion 1.02 Expert opinion on drug delivery 2014 WoS 21 1 6 3 2 1 2 5 1
Scopus 25 2 6 4 3 0 3 2 4 1
189. 5493018 Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF) 1.01 Bioorg. med. chem. 2014 WoS 23 1 0 1 7 8 5 0 1
Scopus 24 1 0 1 8 1 6 6 0 1
190. 9897812 Effect of different parameters used for in vitro gene electrotransfer on gene expression efficiency, cell viability and visualization of plasmid DNA at the membrane level 1.01 J. gene med. 2013 WoS 22 1 3 2 1 2 1 5 4 3
Scopus 24 0 1 3 4 2 2 1 5 3 3
191. 3563377 Specificity determinants for lysine incorporation in Staphylococcus aureus peptidoglycan as revealed by the structure of a MurE enzyme ternary complex 1.01 J Biol Chem 2013 WoS 22 3 1 1 1 3 5 5 1 2
Scopus 24 3 1 2 1 3 5 5 1 3
192. 4843377 Vegetable butters and oils in skin wound healing 1.02 Phytother. res. 2020 WoS 22 2 10 9 1
Scopus 24 3 10 9 2
193. 2505585 Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening 1.01 Bioorg. med. chem. 2009 WoS 21 2 1 1 0 2 2 6 3 2 2
Scopus 24 2 1 1 0 4 2 5 5 1 3
194. 4757617 Chalcone derivatives 1.01 Heliyon 2019 WoS 20 4 8 7 1
Scopus 24 1 4 9 8 2
195. 7830612 Cell-cell electrofusion 1.01 J. membr. biol. 2010 WoS 18 3 2 2 1 1 3 1 1 0 4
Scopus 24 3 2 3 3 1 3 2 1 3 3
196. 2232177 Inhibitors of 17[beta]-hydroxysteroid dehydrogenase type 1 1.02 Curr. med. chem. 2008 WoS 23 2 2 1 5 4 1 5 1 1 1
Scopus 23 3 1 1 5 4 1 5 1 1 1
197. 3886961 4,6- substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human DNA topoisomerase II [alpha] targeting the ATP binding site 1.01 Bioorg. med. chem. 2015 WoS 22 2 6 6 2 3 0 3
Scopus 23 0 2 6 6 2 3 2 2
198. 4515441 Recent progress in the discovery and development of DNA gyrase B inhibitors 1.02 Future medicinal chemistry 2018 WoS 22 2 4 5 4 7
Scopus 23 2 3 6 5 7
199. 4686961 An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors 1.01 Eur. j. med. chem. 2019 WoS 22 4 7 3 7 1
Scopus 23 4 7 3 8 1
200. 3557745 Isolation, analysis and structures of phototoxic fagopyrins from buckwheat 1.01 Food chem. 2014 WoS 22 1 3 2 1 2 3 7 3
Scopus 23 1 3 1 2 4 3 6 3
201. 2637169 Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF 1.01 Bioorg. chem. 2009 WoS 21 1 1 2 1 5 8 2 1
Scopus 23 1 1 1 2 1 5 9 2 1
202. 34441989 Lactone pathway to statins utilizing the Wittig reaction. The synthesis of rosuvastatin 1.01 J. org. chem. 2010 WoS 19 1 4 7 0 2 1 2 1 1
Scopus 23 1 5 7 2 2 1 1 1 2 1
203. 3499889 Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells 1.01 Neuropharmacology 2014 WoS 22 1 3 4 4 3 3 1 3
Scopus 22 0 1 3 4 4 3 3 1 3
204. 4461681 Synthesis and evaluation of N-phenylpyrrolamides as DNA gyrase B inhibitors 1.01 ChemMedChem 2018 WoS 22 0 3 7 8 3 1
Scopus 22 0 3 7 7 4 1
205. 4723057 A MedChem toolbox for cereblon-directed PROTACs 1.01 MedChemComm 2019 WoS 22 1 3 6 10 2
Scopus 22 1 4 6 9 2
206. 4684145 ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents 1.02 Expert opin. ther. pat. 2019 WoS 22 0 7 9 6
Scopus 22 0 7 8 7 0
207. 3008113 Development of screening assays and discovery of initial inhibitors of pneumococcal peptidoglycan deacetylase PgdA 1.01 Biochem. pharmacol. 2011 WoS 21 1 3 2 3 5 2 2 2 1
Scopus 22 1 3 1 3 5 3 3 2 1
208. 30127109 Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB) 1.01 Bioorg. med. chem. lett. 2009 WoS 21 2 2 1 3 1 3 2 3 1 3
Scopus 22 2 3 1 4 2 2 3 2 3
209. 4164977 Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity 1.01 Dalton trans. 2016 WoS 21 0 4 6 5 5 1
Scopus 22 2 3 6 5 5 1
210. 1586012 Cobalt-catalyzed cross-coupling of Grignards with allylic and vinylic bromides 1.01 J. org. chem. 2015 WoS 21 3 3 2 4 2 3 3 1
Scopus 22 3 3 2 5 2 3 3 1
211. 3638897 Excretion pattern of enrofloxacin after oral treatment of chicken broilers 1.03 J. vet. pharmacol. ther. 2014 WoS 20 1 6 2 2 2 7
Scopus 22 1 6 2 2 3 7 1
212. 4022897 Synthesis and biological assessment of racemic benzochromenopyrimidinimines as antioxidant, cholinesterase, and A[sub]ß1-42 aggregation Inhibitors for Alzheimer's disease therapy 1.01 ChemMedChem 2016 WoS 20 1 8 1 3 4 2 1
Scopus 22 1 10 1 3 3 3 1
213. 512412216 Relationship between genome and epigenome - challenges and requirements for future research 1.03 BMC Genomics 2014 WoS 19 1 6 4 2 1 3 2
Scopus 22 1 6 4 4 1 3 1 2
214. 4176497 Mutagenic and carcinogenic structural alerts and their mechanisms of action 1.02 Arh. hig. rada toksikol. 2016 WoS 19 2 5 7 4 1
Scopus 22 2 6 9 4 1
215. 6029908 Electroporator with automatic change of electric field direction improves gene electrotransfer in-vitro 1.01 Biomed. eng. online 2007 WoS 18 1 4 2 3 1 3 2 2
Scopus 22 1 4 1 4 3 3 2 2 1 1
216. 4133233 PACSIN2 polymorphism is associated with thiopurineinduced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy 1.01 Sci. rep. 2016 WoS 16 2 1 4 5 2 2
Scopus 22 3 1 7 5 3 3
217. 1421660 Optimized method for determination of amoxicillin, ampicillin, sulfamethoxazole, and sulfacetamide in animal feed by micellar electrokinetic capillary chromatography and comparison with high-performance liquid chromatography 1.01 Croat. chem. acta 2009 WoS 14 1 1 2 2 1 3 1 1 2
Scopus 22 3 1 2 3 1 3 3 1 3 2
218. 4880241 Two-decades of successful SAR-grounded stories of the novel bacterial topoisomerase inhibitors (NBTIs) 1.01 J. med. chem. 2020 WoS 21 1 7 13
Scopus 21 1 8 12
219. 3001457 Second-generation sulfonamide inhibitors of d-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of d-glutamic acid 1.01 Eur. j. med. chem. 2011 WoS 21 3 2 1 2 2 2 5 3 1
Scopus 21 3 2 1 1 2 1 4 4 2 1
220. 4083825 Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease 1.01 Molecules 2016 WoS 21 1 4 5 3 4 3 1
Scopus 21 1 4 5 3 4 4
221. 7818836 The role of electrophoresis in gene electrotransfer 1.01 J. membr. biol. 2010 WoS 20 2 5 2 1 1 1 4 4
Scopus 21 3 4 3 1 2 1 5 2
222. 512549944 Advanced therapies of skin injuries 1.02 Wien. Klin. Wochenschr. 2015 WoS 19 1 5 5 3 3 1 1
Scopus 21 3 3 5 3 3 3 1
223. 3630449 Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin 1.01 Bioorg. med. chem. lett. 2014 WoS 18 2 2 2 4 3 4 1
Scopus 21 2 2 3 5 3 4 2
224. 21450969 Flavonoids and cinnamic acid esters as inhibitors of fungal 17ß-hydroxysteroid dehydrogenase 1.01 Bioorg. med. chem. 2006 WoS 18 2 3 1 2 1 2 2 2 3
Scopus 21 2 4 1 2 1 3 3 2 3
225. 1961841 Surface analysis of powder binary mixtures with ATR FTIR spectroscopy 1.01 Int. j. pharm. 2006 WoS 16 3 1 3 2 2 1 1 2 1
Scopus 21 3 3 3 2 2 2 2 2 1 1
226. 4154993 S-adenosyl methionine in the therapy of depression and other psychiatric disorders. 1.02 Drug dev. res. 2016 WoS 16 2 7 5 1 1
Scopus 21 1 1 2 2 9 4 1 1
227. 3979633 Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion 1.01 Biol Chem 2016 WoS 21 1 3 1 4 3 3 6
Scopus 16 1 3 1 3 1 2 5
228. 4634737 The pore-forming action of polyenes 1.02 Biochim. biophys. acta, Biomembr. 2019 WoS 15 3 7 5
Scopus 21 3 9 8 1
229. 4872561 Stereoselective activity of 1-propargyl-4-styrylpiperidine-like analogues that can discriminate between monoamine oxidase isoforms A and B 1.01 J. med. chem. 2020 WoS 20 4 6 10
Scopus 20 4 7 9
230. 2162801 New biologically active epidioxysterols from Stereum hirsutum 1.01 Bioorg. med. chem. lett. 2007 WoS 20 1 4 2 1 2 6 2 2
Scopus 20 1 4 2 1 2 1 6 1 2
231. 2063985 Diazenedicarboxamides as inhibitors of D-alanine-D-alanine ligase (Ddl) 1.01 Bioorg. med. chem. lett. 2007 WoS 19 0 3 2 1 3 2 3 4 1
Scopus 20 0 3 2 1 4 2 3 4 1
232. 4505201 Overcoming problems of poor drug penetration into bacteria 1.02 Expert opinion on drug discovery 2018 WoS 19 1 8 3 3 3 1
Scopus 20 2 8 3 4 2 1
233. 4427121 Benzothiazole-based compounds in antibacterial drug discovery 1.02 Curr. med. chem. 2018 WoS 19 1 5 5 8
Scopus 20 1 1 4 5 8 1
234. 4118897 Comparison of in vitro hormone activities of novel flame retardants TBB, TBPH and their metabolites TBBA and TBMEPH using reporter gene assays 1.01 Chemosphere 2016 WoS 19 2 3 4 3 5 2
Scopus 20 0 2 3 4 3 5 3
235. 3580017 Design, synthesis and evaluation of second generation MurF inhibitors based ona cyanothiophene scaffold 1.01 Eur. j. med. chem. 2014 WoS 19 1 5 1 3 3 2 4
Scopus 20 1 6 1 2 5 1 4
236. 4728346 Ellipticines and 9-acridinylamines as inhibitors of d-alanine 1.01 Bioorg. med. chem. 2011 WoS 18 1 3 2 2 3 2 2 2 1
Scopus 20 1 3 2 2 1 3 2 2 3 1
237. 4051313 Synthesis, molecular modelling and biological evaluation of novel heterodimeric, multiple ligands targeting cholinesterases and amyloid beta 1.01 Molecules 2016 WoS 18 3 2 6 4 3 0
Scopus 20 3 2 6 5 4 0 0
238. 5677082 Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF) 1.01 J. comput.-aided mol. des. 2015 WoS 18 0 9 2 3 3 0 1
Scopus 20 0 10 3 1 4 1 1
239. 2895473 Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists 1.01 Molecular diversity 2011 WoS 19 3 1 1 4 2 3 1 2 1 1
Scopus 19 3 1 2 4 1 3 3 1 1
240. 3007857 New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria 1.01 PloS one 2011 WoS 19 5 5 1 2 1 0 1 4
Scopus 19 5 4 2 2 1 0 2 3
241. 9419860 The systematic study of the electroporation and electrofusion of B16-F1 and CHO cells in isotonic and hypotonic buffer 1.08 J. membr. biol. 2012 WoS 19 3 3 1 1 2 3 1 2 3
Scopus 19 3 3 2 1 1 3 2 1 3
242. 6273306 Identification of conserved water sites in protein structures for drug design 1.01 J. chem. inf. mod. 2017 WoS 19 2 3 5 4 5
Scopus 19 2 3 5 4 5
243. 4058394 Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screening 1.01 J. med. chem. 2008 WoS 19 1 3 2 1 2 3 1 2 1 3
Scopus 18 1 3 1 1 2 3 1 2 1 3
244. 32332327 trans-Diastereoselective Ru(II)-catalyzed asymmetric transfer hydrogenation of [alpha]-acetamido benzocyclic ketones via dynamic kinetic resolution 1.01 Org. lett. 2019 WoS 18 3 4 7 4
Scopus 19 2 4 8 5
245. 1670001 Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study 1.01 Eur. j. med. chem. 2005 WoS 18 1 4 2 1 3 4 1 1 1
Scopus 19 1 5 2 4 4 1 2
246. 3556209 2-aminoimidazoles in medicinal chemistry 1.02 Mini rev. med. chem. 2013 WoS 18 2 2 3 3 1 4 1 2
Scopus 19 2 2 3 4 1 4 1 2
247. 2843249 3D QSAR study, synthesis and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the Vesicular AcetylCholine Transporter (VAChT) 1.01 Bioorg. med. chem. 2010 WoS 18 2 2 1 2 2 2 1 3 1 2
Scopus 19 2 2 1 2 2 2 1 4 1 2
248. 3299953 Excretion profile of glycyrrhizin metabolite in human urine 1.01 Food chem. 2012 WoS 18 4 1 3 1 4 2 3
Scopus 19 1 1 3 1 1 3 1 4 2 2
249. 3363185 Computational study of reactivity of bisphenol A-3,4-quinone with deoxyadenosine and glutathione 1.01 Chem. res. toxicol. 2013 WoS 18 2 4 3 2 1 2 1 1 2
Scopus 19 2 5 2 2 1 2 1 1 1 2
250. 3319921 Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes 1.01 Eur J Immunol 2012 WoS 19 2 4 4 0 2 1 2 2 1 1
Scopus 18 2 4 4 0 2 1 2 1 1 1
251. 4620401 Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite 1.01 Chemosphere 2019 WoS 18 2 2 7 7
Scopus 19 2 2 7 7 1
252. 3978865 Structure-activity relationships of novel tryptamine-based inhibitors of bacterial transglycosylase 1.01 J. med. chem. 2015 WoS 17 2 4 1 5 3 2
Scopus 19 3 4 1 5 4 2
253. 38739715 Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets 1.02 Pharmacol. ther. 2021 WoS 17 6 11
Scopus 19 7 11 1
254. 2286193 Novel potent and selective thrombin inhibitors based on a central 1,4-benzoxazin-3(4H)-one scaffold 1.01 J. med. chem. 2008 WoS 19 3 4 2 3 3 1 2 1
Scopus 17 4 5 2 2 0 1 2 1
255. 1993073 A new approach towards peptidosulfonamides: synthesis of potential inhibitors of bacterial peptidoglycan biosynthesis enzymes MurD and MurE 1.01 Tetrahedron 2006 WoS 16 1 1 1 3 2 2 3 3
Scopus 19 1 1 1 4 2 2 4 3 1
256. 3520881 MurD enzymes: some recent developments 1.02 Biomol. concepts 2013                          
Scopus 19 0 0 2 3 0 4 2 4 4
257. 1513585 Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall 1.01 Bioorg. med. chem. lett. 2004 WoS 19 2 2 1 4 2 2 2 2 2
                         
258. 1552497 Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall 1.12 16th International Conference on Phosphorus Chemistry 2004                          
Scopus 19 2 2 1 4 2 2 2 2 2
259. 5867290 Non-targeted chromatographic analyses of cuticular wax flavonoids from Physalis alkekengi L. 1.01 J. chromatogr., A 2016 WoS 18 0 4 3 3 2 4 2
Scopus 18 0 4 3 3 3 3 2
260. 4857713 1-benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease 1.01 Eur. j. med. chem. 2020 WoS 18 4 5 8 1
Scopus 18 4 5 8 1
261. 3440241 Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa with highly overlapped pharmacophores 1.01 Eur. j. med. chem. 2013 WoS 18 0 0 5 2 3 3 3 1 1
Scopus 18 0 0 5 2 3 3 3 1 1
262. 4623217 Reaching toward underexplored targets in antibacterial drug design 1.03 Drug dev. res. 2019 WoS 18 3 4 7 4
Scopus 18 3 4 6 4 1
263. 4473713 Design, synthesis, and biological evaluation of 2-(benzylamino-2-hydroxyalkyl)isoindoline-1,3-diones derivatives as potential disease-modifying multifunctional anti-Alzheimer agents 1.01 Molecules 2018 WoS 18 3 3 6 3 3
Scopus 18 3 3 6 3 3
264. 30102311 Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of tumor necrosis Factor [alpha] 1.01 International immunopharmacology 2017 WoS 18 1 2 4 3 3 5
Scopus 18 1 2 4 3 4 4
265. 1487196 Concise and highly efficient approach to three key pyrimidine precursors for rosuvastatin synthesis 1.01 Tetrahedron 2012 WoS 18 1 5 4 2 3 1 1 1
Scopus 18 1 5 5 2 3 1 1
266. 3602033 Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor 1.01 Eur. j. med. chem. 2014 WoS 17 0 0 0 3 2 3 1 4 4
Scopus 18 0 1 0 2 2 3 2 4 4
267. 4504945 New N-phenylpyrrolamide DNA gyrase B inhibitors 1.01 Eur. j. med. chem. 2018 WoS 17 3 6 5 3
Scopus 18 2 8 4 3 1
268. 3492977 Cinnamic Acid derivatives induce cell cycle arrest in carcinoma cell lines 1.01 Medicinal chemistry 2013 WoS 17 1 1 1 2 3 6 2 1
Scopus 18 1 1 1 1 2 3 5 2 2
269. 27778009 Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3 1.08 Chem.-biol. interact. 2011 WoS 17 0 5 0 3 3 1 1 0 2 2
Scopus 18 0 4 2 3 3 1 1 2 2
270. 3789425 Glucocorticoid-like activity of propylparaben, butylparaben, diethylhexyl phthalate and tetramethrin mixtures studied in the MDA-kb2 cell line 1.01 Toxicol. lett. 2015 WoS 18 0 4 2 3 3 5 1
Scopus 17 0 4 1 3 3 5 1
271. 2281585 A convenient synthesis of 3,4-dihydro-1,4-benzoxazin-2-ones 1.01 Tetrahedron 2008 WoS 17 2 1 4 4 1 3 2
Scopus 18 2 1 4 4 1 3 3
272. 4025969 New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold 1.01 Eur. j. med. chem. 2016 WoS 16 1 3 4 1 4 1 2
Scopus 18 1 3 4 1 4 2 3
273. 3888753 N-phenyl-4,5-dibromopyrrolamides and N-phenylindolamides as ATP competitive DNA gyrase B inhibitors 1.01 J. med. chem. 2015 WoS 16 2 2 2 3 4 2 1
Scopus 18 1 1 2 2 3 4 2 3 0
274. 977521 Trimethylsilyldiazomethane in the preparation of diazoketones via mixed anhydride and coupling reagent methods: a new approach to the Arndt-Eistert synthesis 1.01 Tetrahedron lett. 2001 WoS 16 2 1 1 3 1 1 3 2 1 1
Scopus 18 2 2 1 3 1 2 3 2 1 1
275. 3075953 A 1:1 cocrystal of fluconazole with salicylic acid 1.01 Acta crystallogr., C Cryst. struct. commun. 2011 WoS 15 3 1 1 1 2 2 3 2
Scopus 18 0 4 2 1 1 2 4 2 1 1
276. 7142996 Cell size dynamics and viability of cells exposed to hypotonic treatment and electroporation for electrofusion optimization 1.01 Radiol. oncol. 2009 WoS 15 1 1 2 1 2 1 1 2 1 3
Scopus 18 1 2 3 1 2 1 1 3 1 3
277. 4795256 Identification, in vitro and in vivo antioxidant activity, and gastrointestinal stability of lignans from silver fir (abies alba) wood extract 1.01 J. wood chem. technol. 2017 WoS 14 1 3 2 4 3 1
Scopus 18 1 3 3 5 5 1
278. 31851523 Pyrimido[1,2-b]indazole derivatives 1.01 Eur. j. med. chem. 2021 WoS 17 6 10 1
Scopus 17 6 10 1
279. 1718641 Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities. 1.01 J. med. chem. 2005 WoS 17 1 5 3 2 3 2 1
Scopus 17 1 5 2 3 3 2 1
280. 2074737 Biochemical characterization and physiological properties of Escherichia coli UDP-N-acetylmuramate:L-alanyl-[gamma]-D-glutamyl-meso-diaminopimelate ligase (Mpl) 1.01 J Bacteriol 2007 WoS 17 2 2 1 1 2 3 1 1 4
Scopus 17 2 2 1 1 2 3 1 1 4
281. 3286897 6-arylpyrido[2,3-d]pyrimidines as novel ATP-competitive inhibitors of bacterial D-alanine: D-alanine ligase 1.01 PloS one 2012 WoS 16 0 4 3 2 2 2 1 2 0
Scopus 17 0 5 3 2 2 2 1 2 0
282. 2233969 Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents 1.01 Molecules 2008 WoS 16 2 0 1 1 4 6 1 1
Scopus 17 2 0 1 1 1 3 7 1 1
283. 3274353 Immunomodulatory properties of novel nucleotide oligomerization domain 2 (Nod2) agonistic desmuramyldipeptides 1.01 J. med. chem. 2012 WoS 16 0 1 0 1 3 0 6 2 2 1
Scopus 17 0 1 1 1 3 0 6 2 2 1
284. 3023985 Inhibitors of aldo-keto reductases AKR1C1-AKR1C4 1.02 Curr. med. chem. 2011 WoS 16 2 2 4 1 2 1 1 0 3
Scopus 17 2 1 5 1 2 1 1 4
285. 8189049 Benzoic acid derivatives with improved antifungal activity: design, synthesis, structure-activity relationship (SAR) and CYP53 docking studies 1.01 Bioorg. med. chem. 2015 WoS 16 2 2 3 5 4
Scopus 17 2 2 4 5 4
286. 61513987 Recent advances on smart glycoconjugate vaccines in infections and cancer 1.02 FEBS j. 2022 WoS 16 2 14
Scopus 17 4 13
287. 2564721 Recent advances in the synthesis and applications of reduced amide pseudopeptides 1.02 Curr. med. chem. 2009 WoS 17 1 1 1 2 4 2 3 1 2
Scopus 16 1 1 1 2 3 4 2 2
288. 3666289 Branched [alpha]-D-mannopyranosides; a new class of potent FimH antagonists 1.01 MedChemComm 2014 WoS 16 1 1 3 3 2 1 3 2
Scopus 17 1 1 3 4 2 1 3 2
289. 15755267 N-alkylpiperidine carbamates as potential anti-Alzheimer's agents 1.01 Eur. j. med. chem. 2020 WoS 16 8 8
Scopus 17 9 8 0
290. 1537274819 1,3-diamine-derived bifunctional organocatalyst prepared from camphor 1.01 Advanced Synthesis & Catalysis 2016 WoS 16 2 4 2 5 1 2
Scopus 17 3 3 3 5 1 2
291. 2281300 The anatomy of the fruit in relation to the propensity of citrus species to split 1.01 Sci. hortic. 2001 WoS 15 2 2 1 3 1 1 2 3
Scopus 17 2 2 2 1 2 1 1 2 4
292. 10746708 Comparison of flow cytometry, fluorescence microscopy and spectrofluorometry for analysis of gene electrotransfer efficiency 1.01 J. membr. biol. 2014 WoS 15 0 3 1 1 3 4 3
Scopus 17 0 4 3 1 3 4 2
293. 15647491 The tructural integrity of the model lipid membrane during induced lipid peroxidation 1.01 Antioxidants 2020 WoS 15 1 9 5
Scopus 17 1 9 5 2
294. 3900273 Fagopyrins and protofagopyrins 1.02 J. agric. food chem. 2015 WoS 17 1 1 2 1 1 6 5
Scopus 15 1 1 1 1 1 5 5
295. 58884867 Emerging glyco-based strategies to steer immune responses 1.02 FEBS j. 2021 WoS 15 3 12
Scopus 17 4 13
296. 30078937 Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library 1.01 J. med. chem. 2012 WoS 14 2 1 2 2 1 2 1 3
Scopus 17 2 1 4 2 1 2 1 4
297. 4279665 Endocrine activity of AVB, 2MR, BHA and their mixtures 1.01 Toxicol. sci. 2017 WoS 14 1 1 4 6 2
Scopus 17 1 1 5 7 2 1
298. 11793492 Modular Serial Flow Through device for pulsed electric field treatment of the liquid samples 1.01 Sci. rep. 2017 WoS 14 1 4 4 4 1
Scopus 17 1 6 5 4 1
299. 3274609 MurD enzymes from different bacteria: evaluation of inhibitors 1.01 Biochem. pharmacol. 2012 WoS 13 1 0 1 1 5 1 1 3
Scopus 17 1 1 1 2 1 1 3 2 1 4
300. 3726193 Synthesis and fluorescence properties of environment-sensitive 7-(diethylamino)coumarin derivatives 1.01 Tetrahedron lett. 2014 WoS 16 1 1 3 1 6 2 2
Scopus 16 1 2 3 1 4 3 1 1
301. 2959473 Structure guided development of potent reversibly binding penicillin binding protein inhibitors 1.01 ACS Medicinal Chemistry Letters 2011 WoS 16 5 2 1 3 2 1 0 2
Scopus 16 4 2 1 3 1 2 1 0 2
302. 2739825 MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females 1.01 Clin. biochem. 2010 WoS 15 1 4 3 1 2 3 1
Scopus 16 1 4 2 2 2 2 1 1 1
303. 4641905 Harnessing the untapped potential of NOD ligands for cancer immunotherapy 1.02 Med. res. rev. 2019 WoS 15 4 8 3
Scopus 16 4 8 3 1
304. 3355505 Advances in the synthesis of morpholin-3-ones and morpholin-2-ones 1.02 Synthesis 2012 WoS 15 1 3 1 5 5
Scopus 16 1 1 4 3 2 5
305. 38244355 Cyclic boronates as versatile scaffolds for KPC-2 ß-lactamase inhibition 1.01 RSC med. chem. 2020 WoS 15 0 11 4
Scopus 16 0 12 4
306. 4358513 NMR Methods for identification of false positives in biochemical screens 1.02 J. med. chem. 2017 WoS 15 1 5 6 1 2
Scopus 16 1 3 4 6 1 1
307. 4769905 Organoruthenated nitroxoline derivatives impair tumor cell invasion through inhibition of cathepsin B activity 1.01 Inorg. chem. 2019 WoS 15 0 4 8 3
Scopus 16 0 4 8 4
308. 3063409 Determination of raloxifene and its glucuronides in human urine by liquid chromatography-tandem mass spectrometry assay 1.01 Journal of chromatography 2011 WoS 14 3 1 2 2 2 2 1 1
Scopus 16 4 1 2 2 2 1 2 1 1
309. 3858033 Molecular dynamics to enhance structure-based virtual screening on cathepsin B 1.01 J. comput.-aided mol. des. 2015 WoS 14 1 2 1 1 4 3 1 1
Scopus 16 1 2 1 1 4 3 2 2
310. 2858353 A novel scalable synthesis of pramipexole 1.01 Org. process res. dev. 2010 WoS 14 2 2 2 1 1 2 4
Scopus 16 2 2 2 1 1 2 4 1 1
311. 3861873 Stereochemistry of amino acid spacers determines the pharmacokinetics of 111In-DOTA-minigastrin analogues for targeting of the CCK2/gastrin receptor 1.01 Bioconjug. chem. 2015 WoS 14 1 2 2 1 4 4 0
Scopus 16 1 1 2 2 1 5 4 0
312. 6255642 High performance thin-layer chromatography-mass spectrometry enables reliable analysis of physalins in different plant parts of Physalis alkekengi L. 1.01 J. chromatogr., A 2017 WoS 14 0 3 6 1 3 1
Scopus 16 0 4 7 2 2 1
313. 2982769 Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors 1.01 Eur. j. med. chem. 2011 WoS 16 1 3 3 0 1 1 2 1 2 2
Scopus 14 1 3 3 0 1 2 1 1 2
314. 2360177 Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases 1.01 ChemMedChem 2008 WoS 14 1 2 0 5 1 2 3
Scopus 16 0 1 2 0 6 1 3 3
315. 5462810 Inhibitor design strategy based on an enzyme structural flexibility 1.01 J. chem. inf. mod. 2014 WoS 14 0 3 2 2 3 3 1
Scopus 16 0 3 2 2 1 2 4 1 1
316. 4512625 Preservative efficacy of selected antimicrobials of natural origin in a cosmetic emulsion 1.01 Int. j. cosmet. sci. 2018 WoS 14 2 1 4 6 1
Scopus 16 2 1 7 5 1
317. 4051057 Characterization of endogenous sodium channels in the ND7-23 neuroblastoma cell line 1.01 Assay drug dev. technol. 2016 WoS 14 2 4 2 4 1 1
Scopus 16 1 2 5 2 4 1 1
318. 3733128 Randomized clinical trial 1.01 Journal of functional foods 2016 WoS 12 1 2 2 5 2
Scopus 16 1 1 2 2 2 5 3
319. 1057620 Low temperature influence on flowering in Citrus. The separation of inductive and bud dormancy releasing effects 1.01 Physiol. Plant. 1992 WoS 16 3 2 2 4 2 2 1
                         
320. 3506033 Synthesis of conformationally constrained [gamma]-D-glutamyl-meso -diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1) 1.01 Eur. j. med. chem. 2013 WoS 15 2 4 2 1 2 2 0 2 0
Scopus 15 2 4 2 1 2 2 0 2 0
321. 30074841 N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo/keto reductase AKR1C3 1.01 Bioorg. med. chem. lett. 2012 WoS 15 3 2 3 1 2 1 1 2
Scopus 15 3 2 3 1 2 1 1 2
322. 1836145 Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD 1.01 Bioorg. med. chem. lett. 2005 WoS 15 1 2 5 5 2
Scopus 15 0 1 2 1 4 5 2
323. 2673521 A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering 1.01 BMC Genomics 2009 WoS 15 2 2 1 2 2 4 1 1
Scopus 15 2 2 1 1 2 5 1 1
324. 3075441 A novel fluorescent probe for more effective monitoring of nanosized drug delivery systems within the cells 1.01 Int. j. pharm. 2011 WoS 14 3 1 4 2 2 1 1
Scopus 15 3 2 4 2 2 1 1
325. 22583811 Recent advances in the synthesis of acylboranes and their widening applicability 1.02 ACS omega 2020 WoS 14 8 6
Scopus 15 1 8 6
326. 3977585 A quantum chemical study of the reactivity of acetaminophen (paracetamol) toxic metabolite N-acetyl-p-benzoquinone imine with deoxyguanosine and glutathione 1.01 Chem.-biol. interact. 2015 WoS 15 1 3 4 0 3 2 2
Scopus 14 1 2 4 0 4 1 2
327. 4307825 Enrofloxacin degradation in broiler chicken manure under field conditions and its residuals effects to the environment 1.01 Environ. sci. pollut. res. int. 2017 WoS 13 1 2 1 3 4 2
Scopus 15 1 3 1 3 5 2
328. 2982513 Preparation and reactivity of 5-benzylidenebarbituric and 5-benzylidene-2-thiobarbituric acids 1.01 Acta chim. slov. 2011 WoS 13 2 2 2 2 1 1 1 2
Scopus 15 2 2 2 3 2 1 1 2
329. 4145009 Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2 1.01 Bioorg. med. chem. 2016 WoS 12 1 2 1 5 1 2
Scopus 15 1 2 1 5 2 4
330. 3595633 Molecular docking revealed potential disruptors of glucocorticoid receptor-dependent reporter gene expression 1.01 Toxicol. lett. 2014 WoS 12 1 1 3 2 3 1 1
Scopus 15 1 2 3 1 3 2 2 1
331. 3742833 From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity 1.01 Pharmacogenomics 2014 WoS 12 1 2 2 2 3 2
Scopus 15 1 1 2 3 2 4 2
332. 2224753 Comparison of capillary electrophoresis and high performance liquid chromatography for determination of flavonoids in Achillea millefolium 1.01 J. pharm. biomed. anal. 2008 WoS 12 1 4 1 1 2 1 1 1
Scopus 15 1 4 1 1 2 3 1 1 1
333. 28803331 Folate insufficiency due to MTHFR deficiency Is bypassed by 5-Methyltetrahydrofolate 1.01 J. clin. med. 2020 WoS 12 4 8
Scopus 15 5 10
334. 3086449 Differences among Epilobium and Hypericum species revealed by four IR spectroscopy modes: transmission, KBr tablet, diffuse reflectance and ATR 1.01 Phytochem. anal. 2011 WoS 12 2 1 1 1 0 1 3 1 1 1
Scopus 15 3 1 1 1 3 3 1 1 1
335. 3257201 Simple modification of Karl-Fischer titration method for determination of water content in colored samples 1.01 Journal of Analytical Methods in Chemistry (Print) 2012 WoS 11 1 1 8 1
Scopus 15 1 3 1 1 7 2
336. 2380657 99mTc-labelled rituximab, a new non-Hodgkin's lymphoma, imaging agent: first clinical experience 1.01 Nucl Med Commun 2008 WoS 10 2 2 1 1 1 1 2
Scopus 15 3 2 2 2 2 1 2 1
337. 61605123 Discovery of K V 1.3 ion channel inhibitors 1.02 Med. res. rev. 2021 WoS 9 3 6
Scopus 15 3 8 4
338. 38330627 Bicyclic boronates as potent inhibitors of AmpC, the class C ß-lactamase from escherichia coli 1.01 Biomolecules 2020 WoS 14 3 6 5
Scopus 14 3 6 5
339. 3151985 Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety 1.01 PloS one 2011 WoS 14 3 3 3 1 1 2 0 1
Scopus 14 3 3 3 1 1 2 0 0 1
340. 33050371 Triclocarban, triclosan, bromochlorophene, chlorophene, and climbazole effects on nuclear receptors 1.01 Environ. health perspect. 2020 WoS 13 7 6
Scopus 14 7 6 1
341. 3526257 Isoform selective voltage-gated sodium channel modulators and the therapy of pain 1.02 Curr. med. chem. 2014 WoS 13 1 2 1 1 2 2 4
Scopus 14 1 3 1 3 2 4
342. 35836931 Vaccinomics and adversomics in the era of precision medicine 1.02 J. clin. med. 2020 WoS 13 7 6
Scopus 14 8 5 1
343. 4522609 A patent review of immunoproteasome inhibitors 1.02 Expert opin. ther. pat. 2018 WoS 13 2 2 4 2 3
Scopus 14 2 2 4 2 3 1
344. 2326897 Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one- variable-at-a-time and a new multi-variable-at-a-time approach 1.01 Anal. chim. acta 2008 WoS 14 1 3 1 1 4 1 1 1 1
Scopus 13 1 3 1 1 4 1 1 1
345. 4874609 Synthesis, antiproliferative effect and topoisomerase II inhibitory activity of 3-methyl-2-phenyl-1H-indoles 1.01 ACS Medicinal Chemistry Letters 2020 WoS 13 1 5 7
Scopus 14 1 5 8
346. 2152561 Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation 1.01 Clin Chem Lab Med 2007 WoS 13 2 4 4 1 1 1
Scopus 14 2 4 4 3 1
347. 3870833 D-Glucosamine in iron-catalysed cross-coupling reactions of Grignards with allylic and vinylic bromides 1.01 Appl. organomet. chem. 2015 WoS 14 1 2 2 5 3 0 1
Scopus 13 1 2 2 5 2 0 1
348. 3647601 Bazedoxifene scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists 1.01 J. med. chem. 2014 WoS 13 0 1 1 3 2 4 1 1
Scopus 14 0 1 1 3 1 6 1 1
349. 4364145 FT-IR-based method for rutin, quercetin and quercitrin quantification in different buckwheat (Fagopyrum) species 1.01 Sci. rep. 2017 WoS 12 1 1 5 2 3
Scopus 14 2 2 5 3 2
350. 21449689 Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKC1C1 1.01 Mol. cell. endocrinol. 2006 WoS 14 2 3 0 1 1 1 2 1 3
Scopus 12 1 2 0 1 1 1 2 0 4
351. 2990449 Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor 1.01 Biochem. pharmacol. 2011 WoS 11 1 3 0 2 1 1 1 1 1
Scopus 14 1 4 1 3 1 1 1 1 1
352. 6031276 On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling 1.01 Nucl. med. biol. 2019 WoS 13 3 8 2
Scopus 13 4 7 2
353. 3026289 Virtual screening for potential inhibitors of bacterial MurC and MurD ligases 1.01 J. mol. model. 2012 WoS 13 2 3 2 1 1 2 2
Scopus 13 2 3 2 1 1 2 2
354. 25314777 Trihydroxynaphthalene reductase of Curvularia lunata-A target for flavonoid action? 1.08 Chem.-biol. interact. 2009 WoS 13 2 1 2 2 1 1 2 2
Scopus 13 2 1 2 2 1 1 2 2
355. 3871601 In silico and in vitro investigation of the piperineʼs male contraceptive effect 1.01 Planta Med. 2015 WoS 13 2 2 4 3 2
Scopus 13 1 2 2 3 3 2
356. 4899185 Rational design to biologics development 1.02 Int. j. pharm. 2020 WoS 13 0 4 9
Scopus 13 0 5 7 1
357. 31483609 New antagonists of toll-like receptor 7 discovered through 3D ligand-based virtual screening 1.01 Med. Chem. Res. 2015 WoS 12 1 2 4 2 1 2
Scopus 13 1 2 4 3 3
358. 2612849 S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts 1.01 Biochem. pharmacol. 2009 WoS 12 2 2 1 1 1 3 1 1
Scopus 13 2 2 2 0 1 2 3 1
359. 3210097 Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes 1.01 Biochem. pharmacol. 2012 WoS 12 1 1 2 0 3 1 1 1 2
Scopus 13 1 1 3 0 3 1 1 1 2
360. 4041329 Structural requirements of acylated Gly-l-Ala-d-Glu analogs for activation of the innate immune receptor NOD2 1.01 Eur. j. med. chem. 2016 WoS 12 1 2 3 1 4 1
Scopus 13 0 1 3 2 1 4 2
361. 4483697 Discovery of nanomolar desmuramylpeptide agonists of the innate immune receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) possessing immunostimulatory properties 1.01 J. med. chem. 2018 WoS 13 4 2 5 2
Scopus 12 0 4 2 3 3
362. 7153881 Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase 1.01 J. exp. med. 1996 WoS 12 1 2 2 2 4 1
Scopus 13 1 1 2 3 2 1 2 1
363. 38339075 Broad spectrum ß-lactamase inhibition by a thioether substituted bicyclic boronate 1.01 ACS infect. dis. 2020 WoS 12 0 8 4
Scopus 13 0 9 4
364. 24011815 Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha 1.01 Appl. environ. microbiol. 2010 WoS 11 1 1 1 4 2 0 0 2 0
Scopus 13 1 3 1 4 2 0 0 2 0
365. 1565276 Highly stereoselective formal synthesis of rosuvastatin and pitavastatin through Julia-Kocienski olefination using the lactonized statin side-chain precursor 1.01 Synthesis 2014 WoS 11 6 1 2 1 1
Scopus 13 6 1 2 1 2 1
366. 3391601 Towards dual antithrombotic compounds - Balancing thrombin inhibitory and fibrinogen GPIIb/IIIa binding inhibitory activities of 2,3-dihydro-1,4-benzodioxine derivatives through regio- and stereoisomerism 1.01 Eur. j. med. chem. 2013 WoS 11 0 5 0 1 2 1 1 1
Scopus 13 0 6 0 1 1 2 1 1 1
367. 4249201 Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation 1.01 Neuropharmacology 2017 WoS 10 4 1 3 1 1
Scopus 13 2 4 2 3 1 1
368. 4712561 DPP-4 inhibition 1.02 Pharmacol. ther. 2019 WoS 10 2 4 3 1
Scopus 13 1 6 4 2
369. 21591299 The removal of bisphenols and other contaminants of emerging concern by hydrodynamic cavitation 1.01 Sci. total environ. 2020 WoS 9 2 6 1
Scopus 13 3 9 1
370. 3742577 Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy 1.01 PloS one 2014 WoS 9 2 1 3 1 2
Scopus 13 1 2 2 0 5 1 2
371. 13547267 Impact of nanoscale hindrances on the relationship between lipid packing and diffusion in model membranes 1.01 J. phys. chem., B (Online) 2020 WoS 12 4 4 4
Scopus 12 4 3 4 1
372. 3875953 Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN 1.01 J. mol. model. 2015 WoS 12 1 6 3 1 1 0
Scopus 12 1 5 3 2 1 0
373. 4336753 Peptide microarray analysis of the cross-talk between O-GlcNAcylation and tyrosine phosphorylation 1.01 FEBS Letters 2017 WoS 12 3 1 2 4 2
Scopus 12 3 1 2 5 1
374. 67933443 Exploring protein hotspots by optimized fragment pharmacophores 1.01 Nature communications 2021 WoS 12 2 10
Scopus 12 2 10
375. 13047555 Effect of estrogen-active compounds on the expression of RACK1 and immunological implications 1.01 Arch Toxicol 2020 WoS 11 3 4 4
Scopus 12 3 5 4
376. 4050801 New N-phenyl-4,5-dibromopyrrolamides and N-phenylindolamides as ATPase inhibitors of DNA gyrase 1.01 Eur. j. med. chem. 2016 WoS 11 0 1 3 2 3 1 1
Scopus 12 0 1 3 3 3 1 1 0
377. 2520433 5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reducethe risk of relapse-related acute lymphoblastic leukemia (ALL) 1.01 Leuk. res. 2009 WoS 11 4 0 3 1 2 1
Scopus 12 4 0 4 1 2 1
378. 1438812 (Z)-5-(4-fluorophenyl)pent-4-enoic acid 1.01 Synthesis 2010 WoS 11 2 1 1 3 2 1 1
Scopus 12 2 1 1 3 2 1 2
379. 5024538 Function of the D-Alanine:D-Alanine ligase lid loop 1.01 J. med. chem. 2012 WoS 11 2 1 3 1 2 1 1 0
Scopus 12 2 1 3 2 2 1 1 0
380. 2165617 Synthesis of ethyl 3-(hydroxyphenoxy)benzyl butylphosphonates as potential antigen 85C inhibitors 1.01 Tetrahedron 2007 WoS 11 2 1 1 1 4 2
Scopus 12 1 2 1 1 1 4 2
381. 80096771 Structural basis of prolyl hydroxylase domain inhibition by molidustat 1.01 ChemMedChem 2021 WoS 11 4 7
Scopus 12 3 9
382. 4477553 Cathepsin B inhibitors 1.01 Bioorg. med. chem. lett. 2018 WoS 12 0 1 2 5 4
Scopus 11 0 1 2 4 4
383. 32284931 Natural and synthetic derivatives of hydroxycinnamic acid modulating the pathological transformation of amyloidogenic proteins 1.02 Molecules 2020 WoS 11 3 8
Scopus 12 3 8 1
384. 3022961 Design, synthesis and biological evaluation of novel desmuramyldipeptide analogues 1.01 Eur. j. med. chem. 2011 WoS 11 0 0 0 2 3 1 2 0 2 1
Scopus 12 1 0 0 2 3 1 2 0 2 1
385. 38810629 Discovery of Mycobacterium tuberculosis InhA inhibitors by binding sites comparison and ligands prediction 1.01 J. med. chem. 2016 WoS 10 0 3 1 3 1 2
Scopus 12 0 3 1 5 0 2 1
386. 8747092 The role of electrically stimulated endocytosis in gene electrotransfer 1.01 Bioelectrochemistry 2012 WoS 10 5 1 1 2 1
Scopus 12 5 2 1 1 2 1
387. 5042298 Benzamide derivatives targeting the cell division protein FtsZ 1.01 Antibiotics 2020 WoS 10 2 6 2
Scopus 12 2 7 3
388. 4863345 ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics 1.01 Cell death differ. 2020 WoS 9 2 3 4
Scopus 12 3 4 5
389. 23694041 Adsorption of radiopharmaceuticals to syringes 1.01 Nucl Med Commun 2007 WoS 9 1 4 1 1 1 1
Scopus 12 1 1 1 4 1 1 1 1 1
390. 4051569 Crystallographic study of peptidoglycan biosynthesis enzyme MurD 1.01 PloS one 2016 WoS 9 2 1 2 2 2
Scopus 12 2 1 3 1 3 2
391. 4397681 Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol 1.01 Toxicol. lett. 2018                          
Scopus 12 2 4 4 2
392. 2697073 Synthetic studies towards diazepanone scaffolds 1.01 Tetrahedron: asymmetry 2009 WoS 11 3 3 1 2 2
Scopus 11 3 3 1 2 2
393. 1863025 Metabolism-directed optimisation of antithrombotics: the prodrug principle 1.01 Curr. pharm. des. 2006 WoS 11 3 2 2 3 1
Scopus 11 1 3 2 1 3 1
394. 2366833 Synthesis of 1-C-linked diphosphate analogues of UDP-N-Ac-glucosamine and UDP-N-Ac-muramic acid 1.01 Tetrahedron 2008 WoS 11 1 1 1 1 1 2 2 2
Scopus 11 1 1 1 1 1 1 2 3
395. 3384689 Aromatic fluoro-de-triazenation with boron trifluoride diethyl etherate under non-protic acid conditions 1.01 J. fluorine chem. 2013 WoS 11 1 2 4 2 1 1
Scopus 11 1 4 3 2 1
396. 1536946115 Discovery of 'click' 1,2,3-triazolium salts as potential anticancer drugs 1.01 Radiol. oncol. 2016 WoS 11 0 2 2 1 4 2
Scopus 11 0 2 2 2 3 2
397. 36732421 Synthesis of pyrazolo[1,2-a]pyrazole-based peptide mimetics 1.01 Tetrahedron 2013 WoS 11 0 2 0 1 1 1 2 2 1 1
Scopus 11 0 2 0 1 1 1 2 2 1 1
398. 5563162 Evaluation of Michael-type acceptor reactivity of 5-benzylidenebarbiturates, 5-benzylidenerhodanines, and related heterocycles using NMR 1.01 Acta chim. slov. 2014 WoS 11 1 2 1 2 3 1 1
Scopus 11 1 1 1 2 4 2
399. 1563249 Solid-phase synthesis of amidines by the reduction of amidoximes 1.01 Tetrahedron lett. 2004 WoS 11 2 2 2 1 1 1 2
Scopus 11 2 2 2 1 1 1 2
400. 3588465 2-Amino-5-alkylidenethiazol-4-ones as promising lipid peroxidation inhibitors 1.01 Monatsh. Chem. 2014 WoS 11 1 2 3 2 1 2
Scopus 11 1 2 3 2 1 2
401. 30257369 Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenase 1.01 J. chem. inf. mod. 2012 WoS 10 1 1 2 1 3 1 1
Scopus 11 1 3 1 1 3 1 1
402. 25125123 DPP-4 inhibitors in the prevention/treatment of pulmonary fibrosis, heart and kidney injury caused by covid-19-a therapeutic approach of choice in type 2 diabetic patients? 1.01 Front Pharmacol 2020 WoS 11 1 6 4
Scopus 10 1 7 2
403. 3068017 Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5- triazin-2(1H)-ones as inhibitors of cathepsin B 1.01 Eur. j. med. chem. 2011 WoS 10 1 2 1 1 0 1 2 1 1
Scopus 11 1 2 2 1 0 1 2 1 1
404. 11691348 Cell stress response to two different types of polymer coated cobalt ferrite nanoparticles 1.01 Toxicol. lett. 2017 WoS 9 1 3 0 2 1 2
Scopus 11 1 3 1 3 2 1
405. 5274906 Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Asl [sub] fm) 1.01 Eur. j. med. chem. 2013 WoS 9 0 0 1 3 1 1 3
Scopus 11 0 0 1 1 3 1 1 4
406. 6615834 Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase II [alpha] 1.01 Eur. j. med. chem. 2019 WoS 9 4 2 2 1
Scopus 11 6 2 2 1
407. 2622321 Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond 1.02 Pharmacogenomics 2009 WoS 9 1 0 1 1 2 2 2
Scopus 11 0 1 1 2 2 2 3
408. 2374513 Surface active stabilizer Tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells 1.01 Toxicol. appl. pharmacol. 2008 WoS 9 3 1 1 1 1 1 1
Scopus 11 4 1 1 1 1 1 2
409. 3367793 Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures 1.01 Acta pharm. 2012 WoS 9 1 1 2 3 2
Scopus 11 2 1 1 2 3 2
410. 27947481 Biochemical and biological evaluation of novel potent coumarin inhibitor of 17ß-HSD type 1 1.08 Chem.-biol. interact. 2011 WoS 9 5 1 2 1
Scopus 11 6 1 2 1 1
411. 4892017 Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90 1.01 Bioorg. chem. 2020 WoS 8 4 2 2
Scopus 11 5 2 4
412. 3803505 Characterization of human lymphoblastoid cell lines as a novel in vitro test system to predict the immunotoxicity of xenobiotics 1.01 Toxicol. lett. 2015 WoS 7 1 2 2 1 1
Scopus 11 2 3 2 1 2 1
413. 3042161 Novel inhibitors of trihydroxynaphthalene reductase with antifungal activity identified by ligand-based and structure-based virtual screening 1.01 J. chem. inf. mod. 2011 WoS 6 2 2 1 1
Scopus 11 3 1 3 1 2 1
414. 7818580 Analysis and comparison of electrical pulse parameters for gene electrotransfer of two different cell lines 1.01 J. membr. biol. 2010 WoS 3 0 1 1 1 0 0
Scopus 11 2 4 1 3 1 0 0
415. 1629809 Peptidomimetic thrombin inhbibitors 1.01 Pathophysiology of haemostasis and thrombosis 2004 WoS 11 2 1 2 2 1 3
                         
416. 86644739 Treatment of benign prostatic hyperplasia by natural drugs 1.02 Molecules 2021 WoS 11 9 2
                         
417. 1863281 99mTc-rituximab radiolabelled by photo-activation: a new non-Hodgkins lymphoma imaging agent 1.01 Eur. j. nucl. med. mol. imaging 2006 WoS 10 2 2 1 4 1
Scopus 10 3 2 1 3 1
418. 4857457 In vitro estrogenic activity of binary and multicomponent mixtures with bisphenol A 1.01 Sci. total environ. 2020 WoS 10 1 4 5
Scopus 10 3 2 5
419. 47675139 WIDOCK 1.01 J. comput.-aided mol. des. 2021 WoS 10 2 8
Scopus 10 4 5 1
420. 46272259 Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds 1.01 Nature communications 2021 WoS 10 5 4 1
Scopus 10 6 2 2
421. 1647985 Recent advances in design, synthesis and biological activity of aminoalkylsulfonates and sulfonamidopeptides 1.01 Curr. med. chem. 2004 WoS 10 3 1 1 1 1 1 1 1
Scopus 10 3 1 1 1 1 1 1 1
422. 2985329 DC-SIGN ligation greatly affects dendritic cell differentiation from monocytescompromising their normal function 1.01 J. leukoc. biol. 2011 WoS 10 2 0 1 4 1 2
Scopus 10 2 0 1 4 1 2
423. 4616561 Methylation of selenocysteine catalysed by thiopurine S-methyltransferase 1.01 Biochim. biophys. acta (G) 2019 WoS 10 2 2 4 2
Scopus 10 2 1 5 2
424. 4235633 Antibacterial and antibiofilm potentials of marine pyrrole-2-aminoimidazole alkaloids and their synthetic analogs 1.02 Mini rev. med. chem. 2018 WoS 10 4 1 5
Scopus 10 4 2 4
425. 4142961 New brominated flame retardants and their metabolites as activators of the pregnane X receptor 1.01 Toxicol. lett. 2016 WoS 9 1 2 4 0 1 1
Scopus 10 1 2 4 0 2 1
426. 1666161 Effect of preparation in solvent evaporation process on Eudragit RS microsphere properties 1.01 Chem. Pharm. Bull. 2005 WoS 9 1 1 4 2 1
Scopus 10 2 1 4 2 1
427. 4869233 Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes 1.01 J. enzyme inhib. med. chem. 2020 WoS 9 3 1 3 2
Scopus 10 3 1 4 2
428. 4494449 Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids 1.01 MedChemComm 2018 WoS 10 1 3 5 1
Scopus 9 1 2 5 1
429. 31846915 Assessment of tractable cysteines by covalent fragments screenings 1.01 ChemBioChem 2021 WoS 10 5 5
Scopus 9 4 5
430. 2988913 Cathepsin X cleavage of the ß2 integrin regulates talin-binding and LFA-1 affinity in T cells 1.01 J. leukoc. biol. 2011 WoS 9 1 1 2 1 1 0 2 1
Scopus 10 1 1 2 1 1 0 3 1
431. 2251377 Identification of herbarium whole-leaf samples of Epilobium species by ATR-IRspectroscopy 1.01 Chem. biodivers. 2008 WoS 9 2 1 1 1 1 2 1
Scopus 10 3 1 1 1 1 1 1 1
432. 1499740 The use of a lactonized statin side-chain precursor in a concise and efficient assembly of pitavastatin 1.01 Synthesis 2012 WoS 9 1 2 5 1
Scopus 10 1 2 5 1 1
433. 4686193 Rutin as deoxyribonuclease I inhibitor 1.01 Chem. biodivers. 2019 WoS 9 3 4 2
Scopus 10 3 4 2 1
434. 4738929 Efficient synthesis and preliminary biological evaluations of trifluoromethylated imidazo[1,2-a]pyrimidines and benzimidazo[1,2-a]pyrimidines 1.01 New j. chem. 2019 WoS 10 8 2
Scopus 8 1 5 2
435. 9424468 Electrofusion of B16-F1 and CHO cells 1.01 Bioelectrochemistry 2012 WoS 8 1 1 0 0 0 2 1 3
Scopus 10 0 1 1 0 1 1 1 1 4
436. 81287683 Influence of linker attachment points on the stability and neosubstrate degradation of cereblon ligands 1.01 ACS Medicinal Chemistry Letters 2021 WoS 8 7 1
Scopus 10 8 2
437. 3477105 Biochemical characterization of MurF from Streptococcus pneumoniae and the identification of a new MurF inhibitor through ligand-based virtual screening 1.01 Acta chim. slov. 2013 WoS 10 0 1 4 3 1 1
Scopus 8 0 4 2 2
438. 4843121 Herbal preparations for the treatment of hair loss 1.02 Arch. dermatol. res. 2020 WoS 8 2 6
Scopus 10 2 8
439. 6587988 Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma cells 1.01 Bioelectrochemistry 2008 WoS 8 1 1 1 1 4
Scopus 10 1 1 1 1 2 4
440. 62365443 Overcoming challenges of HERG potassium channel liability through rational design 1.02 Med. res. rev. 2021 WoS 8 3 5
Scopus 10 3 5 2
441. 3027569 Multitarget cardiovascular drugs 1.02 Curr. med. chem. 2011 WoS 8 1 1 2 1 1 2
Scopus 10 1 1 2 1 2 1 2
442. 3086193 Commonly applied smoothing of IR spectra showed unappropriate for the identification of plant leaf samples 1.01 Chemometr. intell. lab. syst. 2011 WoS 7 0 1 3 1 1 1
Scopus 10 0 1 1 4 1 1 2
443. 4217713 Cardioprotective effects of silver fir (Abies alba) extract in ischemic-reperfused isolated rat hearts 1.01 Food & nutrition research 2016 WoS 7 0 3 1 2 1
Scopus 10 0 2 3 2 3
444. 89011971 Drug delivery strategies for curcumin and other natural Nrf2 modulators of oxidative stress-related diseases 1.02 Pharmaceutics 2021 WoS 7 7
Scopus 10 7 3
445. 2088817 Preparation of amidines by amidoxime reduction with potassium formate 1.03 Synlett 2007 WoS 9 2 1 3 1 1 1
Scopus 9 2 1 3 1 1 1
446. 4654961 Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays 1.01 Chemosphere 2019 WoS 9 3 5 1
Scopus 9 3 5 1
447. 3081841 Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells 1.01 Prostaglandins Other Lipid Mediat 2011 WoS 9 4 2 0 1 1 0 1
Scopus 9 4 2 0 1 1 0 1
448. 2505841 New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3 1.01 Eur. j. med. chem. 2009 WoS 9 0 1 2 1 2 1 1 1
Scopus 9 0 1 2 1 2 1 1 1
449. 4658033 An overview, advantages and therapeutic potential of non-peptide positive allosteric modulators of glucagon-like peptide-1 receptor 1.02 ChemMedChem 2019 WoS 9 4 4 1
Scopus 9 1 3 4 1
450. 2062705 Phosphinate Inhibitors of UDP-N-Acetylmuramoyl-L-Alanyl-D-Glutamate: L-Lysine Ligase (MurE) 1.01 Arch. Pharm. 2007 WoS 9 1 1 1 4 2
Scopus 9 0 2 1 4 2
451. 2068593 Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation in the Slovenian population 1.03 Clin. biochem. 2007 WoS 9 1 1 1 2 2 2
Scopus 9 1 1 1 2 2 2
452. 3500145 Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones 1.01 Molecular diversity 2013 WoS 9 0 2 1 2 1 2 1
Scopus 9 0 2 1 2 1 2 1
453. 4900977 Design and synthesis of 3,5-substituted 1,2,4-oxadiazoles as catalytic inhibitors of human DNA topoisomerase II[alpha] 1.01 Bioorg. chem. 2020 WoS 9 1 2 6
Scopus 9 1 2 6
454. 28563161 Neutrophil defensins but not interleukin-6 in vaginal fluid after preterm premature rupture of membranes predict fetal/neonatal inflammation and infant neurological impairment 1.01 Acta obstet. gynecol. Scand. 2011 WoS 8 1 1 3 2 1
Scopus 9 1 1 3 1 1 1 1
455. 4896625 Synthesis and evaluation of anticancer activity of new 9-acridinyl amino acid derivatives 1.01 RSC med. chem. 2020 WoS 8 1 1 5 1
Scopus 9 1 1 6 1
456. 4360049 Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels 1.01 Eur. j. med. chem. 2017 WoS 9 2 2 1 2 2
Scopus 8 2 2 2 2
457. 23240451 Development of a stability-indicating analytical method for determination of venetoclax using AQbD principles 1.01 ACS omega 2020 WoS 8 5 2 1
Scopus 9 3 5 1
458. 6391066 HPTLC-densitometric and HPTLC-MS methods for analysis of flavonoids 1.01 J. liq. chromatogr. relat. technol. 2018 WoS 8 2 2 3 1
Scopus 9 2 2 4 1
459. 5145882 The binding mode of second-generation sulfonamide inhibitors of MurD 1.01 PloS one 2012 WoS 8 2 0 1 1 2 1 1
Scopus 9 0 2 0 1 1 2 1 1 1
460. 3331441 Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis 1.01 Eur. j. med. chem. 2012 WoS 8 0 3 1 1 1 2
Scopus 9 0 3 1 1 2 2
461. 3165297 Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a ß-ketophosphonate structure 1.01 Organic and Biomolecular Chemistry 2011 WoS 9 3 1 1 2 1 1
Scopus 8 2 1 1 2 1 1
462. 1538414787 Half-sandwich Ir(III) and Os(II) complexes of pyridyl-mesoionic carbenes as potential anticancer agents 1.01 Organometallics 2019 WoS 8 2 6
Scopus 9 2 6 1
463. 4639601 Heterocyclic electrophiles as new MurA inhibitors 1.01 Arch. Pharm. 2018 WoS 8 2 3 3
Scopus 9 3 3 3
464. 1555036 Study of chemoselective asymmetric hydrogenation of (1-bromo-1-alkenyl)boronicesters with iridium-P^N complexes 1.01 Tetrahedron 2014 WoS 8 1 2 1 1 1 1 1
Scopus 9 1 2 1 1 1 2 1
465. 1943665 Glycerolipids as selective thrombin inhibitors from the fungus Stereum Hirsutum 1.01 Drug dev. ind. pharm. 2006 WoS 8 2 2 2 1 1
Scopus 9 2 2 2 2 1
466. 1552241 Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease 1.01 Genes cells 2004 WoS 7 1 1 1 1 1 1 1
Scopus 9 1 1 2 1 1 1 1 1
467. 15039491 Anomalies detected during hydrodynamic cavitation when using salicylic acid dosimetry to measure radical production 1.01 Chem. eng. j. 2020 WoS 7 2 4 1
Scopus 9 1 1 6 1
468. 29153795 Discovery of novel Hsp90 C-terminal inhibitors using 3D-pharmacophores derived from molecular dynamics simulations 1.01 Int. j. mol. sci. 2020 WoS 7 3 4 0
Scopus 9 3 5 1
469. 3193713 Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins 1.01 J Steroid Biochem Mol Biol 2012 WoS 9 0 1 0 2 1 1 2 2
Scopus 7 0 1 0 2 1 1 2
470. 4657777 Synthesis of thicolchicine - based conjugates 1.01 ChemPlusChem 2019 WoS 6 1 2 1 2
Scopus 9 1 2 1 3 2
471. 3577713 Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulators 1.01 J. chem. inf. mod. 2013 WoS 8 0 0 1 0 2 1 2 2
Scopus 8 0 0 1 0 2 1 2 2
472. 27754457 Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients 1.01 Transplant. proc. 2010 WoS 8 3 1 1 1 1 1
Scopus 8 3 1 1 1 1 1
473. 3497585 Coumarin-based dual fluorescent spin-probes 1.01 Tetrahedron lett. 2013 WoS 8 2 1 3 1 1
Scopus 8 2 1 3 1 1
474. 4724337 New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors 1.01 MedChemComm 2019 WoS 8 3 4 1
Scopus 8 3 3 2
475. 992625 Influence of chirality of the preceding acyl moiety on the cis/trans ratio of the proline peptide bond 1.01 J. org. chem. 2001 WoS 8 3 1 1 1 1 1
Scopus 8 3 1 1 1 1 1
476. 4642161 Analogs of the lignan pinoresinol as novel lead compounds for P-glycoprotein (P-gp) inhibitors 1.01 ACS Medicinal Chemistry Letters 2018 WoS 8 1 2 4 1
Scopus 8 1 2 4 1
477. 3642481 Antioxidant activity and phenolic content of Bergenia crassifolia, B. x ornata and B. ciliata 1.01 Natural product communications 2014 WoS 8 1 2 2 2 1
Scopus 8 0 2 3 2 1
478. 1537675459 Construction of vicinal tetrasubstituted stereogenic centers via a Mannich-type organocatalyzed addition of [Delta] [sup] 2-pyrrolin-4-ones to isatine imines 1.01 Advanced Synthesis & Catalysis 2018 WoS 8 2 2 3 1
Scopus 8 2 2 3 1
479. 4477809 Discovery of isatin and 1H-indazol-3-ol derivatives as D-amino acid oxidase (DAAO) inhibitors 1.01 Bioorg. med. chem. 2018 WoS 8 1 1 2 1 3
Scopus 8 1 1 2 1 3
480. 1360220 Novel inhibitors of ß-ketoacyl-ACP reductase from Escherichia coli 1.08 Chem.-biol. interact. 2009 WoS 8 0 1 2 2 1 2
Scopus 8 0 1 2 2 1 2
481. 1538522051 Pyridine wingtip in [Pd(Py-tzNHC) [sub] 2] [sup] 2+ complex is a proton shuttle in the catalytic hydroamination of alkynes 1.01 Org. lett. 2020 WoS 8 2 5 1
Scopus 8 2 4 2
482. 2510676 Model-based automated detection of mammalian cell colonies 1.01 Phys. Med. Biol. 2001 WoS 7 1 1 1 1 1 1 1
Scopus 8 1 1 1 1 1 1 1 1
483. 1576796 A DMAP-catalyzed approach to the industrial-scale preparation of n-6-demethylated 9,10-dihydrolysergic acid methyl ester: a key cabergoline andpergolide precursor 1.01 Org. process res. dev. 2015 WoS 7 1 2 2 1 1
Scopus 8 1 2 1 2 1 1
484. 4765297 Discovery of immunoproteasome inhibitors using large-scale covalent virtual screening 1.01 Molecules 2019 WoS 7 2 3 2
Scopus 8 2 4 2
485. 31706329 Hypoglycemia in venlafaxine overdose 1.03 Eur J Clin Pharmacol 2015 WoS 8 1 1 2 2 2
Scopus 7 1 2 2 2
486. 17380355 A facile synthesis of ligands for the von Hippel-Lindau E3 ligase 1.01 Synthesis 2020 WoS 7 1 3 3
Scopus 8 1 3 4
487. 58066947 Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and [gamma]-aminobutyric acid transporters 1.01 Eur. j. med. chem. 2021 WoS 7 1 6
Scopus 8 1 6 1
488. 3873649 An overview of recent dipeptidyl peptidase-IV inhibitors 1.02 Curr. topics med. chem. 2015 WoS 7 1 1 3 1 1
Scopus 8 1 2 2 1 2
489. 3408212 Effect of surfactant polyoxyethylene glycol (C[sub]12E[sub]8) on electroporation of cell line DC3F 1.01 Colloids surf., A Physicochem. eng. asp. 2003 WoS 7 1 1 1 1 2 0 1
Scopus 8 1 2 1 1 2 0 1
490. 2480497 Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1 1.08 Chem.-biol. interact. 2009 WoS 8 1 1 1 1 1 3
Scopus 7 1 1 1 1 1 2
491. 26759429 Reaction of methyl (2E)-3-dimethylamino-2-(1H-indol-3-yl)-propenoate with ureas 1.01 Tetrahedron 2005 WoS 7 2 1 0 0 1 1 1 1
Scopus 8 2 1 0 0 2 1 1 1
492. 4360305 Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo 1.01 Oncotarget 2017 WoS 8 1 4 1 2 0
Scopus 7 2 2 1 2 0
493. 25421317 A novel approach to substituted 1,3-selenazole core as a precursor of electron rich olefins: diselendiazafulvalene and azino-diselenadiazafulvalene 1.01 New j. chem. 2003 WoS 6 1 1 1 2 1
Scopus 8 1 1 1 1 2 1 1
494. 69036803 Targeted cancer therapy using compounds activated by light 1.02 Cancers 2021 WoS 6 1 5
Scopus 8 1 6 1
495. 34389209 Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds 1.01 Eur. j. med. chem. 2019 WoS 6 1 3 2
Scopus 8 1 4 3
496. 3843441 Chemistry of 2-aminoimidazoles 1.02 J. heterocycl. chem. 2016 WoS 6 1 1 2 2
Scopus 8 1 2 2 2 1
497. 4371057 Repositioning drugs for rare immune diseases 1.02 Curr. med. chem. 2018 WoS 6 1 2 2 1
Scopus 8 1 1 2 2 2
498. 34301957 The influence of electroporation on cytotoxicity of anticancer ruthenium(III) complex KP1339 in vitro and in vivo 1.01 Anticancer res. 2010 WoS 6 0 2 1 0 2 1
Scopus 8 0 3 1 1 2 1
499. 88347651 Herbal products used in menopause and for gynecological disorders 1.02 Molecules 2021 WoS 6 5 1
Scopus 8 6 2
500. 3061361 Thrombin inhibitors with lipid peroxidation and lipoxygenase inhibitory activities 1.01 Bioorg. med. chem. lett. 2011 WoS 5 1 2 1 1
Scopus 8 2 2 1 1 2
501. 2530161 Analysis of atorvastatin and related substances by MEKC 1.01 Chromatographia 2009 WoS 5 1 1 1 1 1
Scopus 8 2 1 1 1 2 1
502. 1431665 Mutations in galactose-1-phosphate uridyltransferase gene in patients with idiopathic presenile cataract 1.01 J. inherit. metab. dis. 2003 WoS 4 1 1 1 1
Scopus 8 3 1 2 1 1
503. 2113393 Precision of micellar electrokinetic capillary chromatography in the determination of seven antibiotics in pharmaceuticals and feedstuffs 1.01 Anal. chim. acta 2007 WoS 7 2 3 2
Scopus 7 2 3 2
504. 4683633 New coumarin- and phenoxazine-based fluorescent probes for live-cell STED nanoscopy 1.01 Eur. biophys. j. 2019 WoS 7 2 4 1
Scopus 7 1 3 2 1
505. 3085937 Discovery of highly potent, nonsteroidal 17ß-hydroxysteroid dehydrogenase type 1 inhibitors by virtual high-throughput screening 1.01 J Steroid Biochem Mol Biol 2011 WoS 7 1 1 3 1 1
Scopus 7 1 1 3 2
506. 3966577 STD NMR and molecular modelling insights into interaction of novel mannose-based ligands with DC-SIGN 1.01 Organic and Biomolecular Chemistry 2016 WoS 7 1 1 2 2 1
Scopus 7 1 1 2 2 1
507. 4076884 Shape transformation and burst of giant POPC unilamellar liposomes modulated by non-ionic detergent C_12E_8 1.01 Chem. phys. lipids 2003 WoS 7 1 1 1 4
Scopus 7 1 1 1 4
508. 3958129 In silico discovery of novel potent antioxidants on the basis of pulvinic acid and coumarine derivatives and their experimental evaluation 1.01 PloS one 2015 WoS 7 2 0 4 1
Scopus 7 1 1 0 3 2
509. 1551473 Influence of herbicide, 2,4-dichlorophenoxy acetic acid, on haemocyte DNA of in vivo treated mussel 1.01 J. exp. mar. biol. ecol. 2004 WoS 7 1 2 2 1 1
Scopus 7 1 2 2 1 1
510. 3007601 Nitroxide-fluorophore double probes: a potential tool for studying membrane heterogeneity by ESR and fluorescence 1.01 Organic and Biomolecular Chemistry 2011 WoS 7 1 4 1 1
Scopus 7 1 4 1 1
511. 3398769 Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity 1.01 Appl. microbiol. biotechnol. 2013 WoS 7 2 0 0 0 2 1 1 1
Scopus 7 3 0 0 0 2 1